KR102454110B1 - Recombinant plasmids and mutant strains for screening inhibitors of ppGpp biosynthesis-related gene expression - Google Patents
Recombinant plasmids and mutant strains for screening inhibitors of ppGpp biosynthesis-related gene expression Download PDFInfo
- Publication number
- KR102454110B1 KR102454110B1 KR1020200084688A KR20200084688A KR102454110B1 KR 102454110 B1 KR102454110 B1 KR 102454110B1 KR 1020200084688 A KR1020200084688 A KR 1020200084688A KR 20200084688 A KR20200084688 A KR 20200084688A KR 102454110 B1 KR102454110 B1 KR 102454110B1
- Authority
- KR
- South Korea
- Prior art keywords
- ppgpp
- biosynthesis
- gene
- recombinant plasmid
- related gene
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
본 발명은 ppGpp 생합성 관련 유전자 발현 저해물질 탐색용 재조합 플라스미드, 상기 재조합 플라스미드를 이용한 ppGpp 생합성 관련 유전자 발현 저해물질 탐색용 돌연변이 균주의 제조방법, 상기 방법으로 제조된 돌연변이 균주 및 상기 돌연변이 균주를 이용한 ppGpp 생합성 관련 유전자 발현 저해물질의 탐색 방법에 관한 것으로, 상기 재조합 플라스미드 및 돌연변이 균주는 ppGpp 생합성 관련 유전자의 프로모터 부위와 프로모터가 없는 항생제 저항성 유전자를 포함함으로써 ppGpp 생합성 관련 유전자의 프로모터에 의해 항생제 저항성 유전자 발현이 조절되고, 상기 돌연변이 균주를 이용한 저해물질 탐색 과정에서 항생제가 첨가된 배지에서 균의 성장을 측정함으로써 ppGpp 생합성 관련 유전자 발현의 저해물질을 손쉽게 탐색할 수 있다.The present invention relates to a recombinant plasmid for screening ppGpp biosynthesis-related gene expression inhibitors, a method for preparing a mutant strain for screening ppGpp biosynthesis-related gene expression inhibitors using the recombinant plasmid, the mutant strain prepared by the above method, and ppGpp biosynthesis using the mutant strain It relates to a screening method for a related gene expression inhibitor, wherein the recombinant plasmid and the mutant strain include the promoter region of the ppGpp biosynthesis-related gene and the antibiotic resistance gene without a promoter, so that the expression of the antibiotic resistance gene is regulated by the promoter of the ppGpp biosynthesis-related gene. In the process of screening for inhibitors using the mutant strain, it is possible to easily search for inhibitors of ppGpp biosynthesis-related gene expression by measuring the growth of bacteria in a medium to which antibiotics are added.
Description
본 발명은 생물의 신호전달 경로에 관여하는 ppGpp의 생합성 관련 유전자 발현의 저해물질을 탐색하기 위한 재조합 플라스미드 및 돌연변이 균주에 관한 것으로, 보다 구체적으로 ppGpp 생합성 관련 유전자 발현 저해물질 탐색용 재조합 플라스미드, 상기 재조합 플라스미드를 이용한 ppGpp 생합성 관련 유전자 발현 저해물질 탐색용 돌연변이 균주의 제조방법, 상기 방법으로 제조된 돌연변이 균주 및 상기 돌연변이 균주를 이용한 ppGpp 생합성 관련 유전자 발현 저해물질의 탐색 방법에 관한 것이다.The present invention relates to a recombinant plasmid and a mutant strain for screening for inhibitors of ppGpp biosynthesis-related gene expression involved in the signaling pathway of organisms, and more specifically, to a recombinant plasmid for screening for ppGpp biosynthesis-related gene expression inhibitors, the recombination It relates to a method for producing a mutant strain for screening ppGpp biosynthesis-related gene expression inhibitors using a plasmid, the mutant strain prepared by the above method, and a screening method for a ppGpp biosynthesis-related gene expression inhibitor using the mutant strain.
아시네토박터 바우마니(Acinetobacter baumannii)는 감마프로테오박테리아(Gammaproteobacteria)에 속하는 그람음성균으로서 토양, 물 등의 자연 환경에 널리 분포하며, 면역력이 강한 건강한 사람에게는 약한 병원성을 보이나, 면역 시스템이 손상 또는 약화된 사람들에게서 높은 독성을 보이는 기회감염균이다. 특히, 카바페넴계(carbapenems), 아미노글리코사이드계(aminoglycosides), 플로로퀴놀론계(fluoroquinolones) 등의 항생제에 내성을 갖는 다제내성(multiple drug resistance, MDR) 특성으로 인해 중환자실 환자 감염과 같은 원내 감염(hospital-acquired infection)의 주요 병원균으로 주목 받고 있으며, 아시네토박터 바우마니 감염 시 폐렴, 심내막염, 혈류감염, 요로감염, 복막염 등을 포함한 다양한 감염증을 일으킨다. 아시네토박터 바우마니 감염증을 치료하기 위해서 콜리스틴(colistin), 티지사이클린(tigecycline), 이미페넴(imipenem), 메로페넴(meropenem)과 같은 항생제들이 주로 처방되지만, 이들에 대해서도 장기간 사용 시 저항성이 나타나므로 아시네토박터 바우마니에 대한 새로운 저해 물질의 개발이 여전히 요구되고 있다. Acinetobacter baumannii is a gram-negative bacterium belonging to Gammaproteobacteria that is widely distributed in natural environments such as soil and water, and shows weak pathogenicity to healthy people with strong immunity, but the immune system is damaged or It is an opportunistic pathogen with high toxicity in weakened individuals. In particular, due to the characteristics of multiple drug resistance (MDR) with resistance to antibiotics such as carbapenems, aminoglycosides, and fluoroquinolones, hospitals such as intensive care unit infections It is attracting attention as a major pathogen of hospital-acquired infection, and Acinetobacter baumani infection causes various infections including pneumonia, endocarditis, bloodstream infection, urinary tract infection, and peritonitis. Antibiotics such as colistin, tigecycline, imipenem, and meropenem are mainly prescribed to treat Acinetobacter baumani infection, but even these antibiotics show resistance when used for a long time. The development of new inhibitors against Acinetobacter baumani is still required.
한편, ppGpp는 박테리아의 생장 조절 및 항생제에 대한 내성(tolerance), 독성 유전자의 발현 등 다양한 스트레스 반응에 관여하는 신호전달 분자로 역할을 하는 2차 전달물질(secondary messenger)이다. ppGpp 활성화는 항균 치료의 임상 성공 및 효과에 큰 영향을 미치는데, 박테리아 내에서 ppGpp가 부재할 경우에는 체내에서 합성되는 아미노산이 부족하여 생존이 어려울 뿐만 아니라 세포의 비정상적인 분열 또는 부동화(immobility)가 야기될 수 있다. 최근 본 발명자들의 연구에서는 ppGpp가 다제내성균인 A. baumannii에서 EP(efflux pump) 관련 유전자의 발현을 조절하여 항생제 민감성에 영향을 미친다는 것을 확인하였으며, 효과적인 항생제가 없는 A. baumannii에 대해 ppGpp 생합성과 관련된 A1S_0579 유전자가 새로운 항생 물질의 대상이 될 수 있음을 제시하였다 (J Antimicrob Chemother. 2020. HW Jung, et al.).On the other hand, ppGpp is a secondary messenger that serves as a signaling molecule involved in various stress responses such as bacterial growth regulation, tolerance to antibiotics, and expression of toxic genes. Activation of ppGpp has a great impact on the clinical success and effectiveness of antibacterial treatment. In the absence of ppGpp in bacteria, the amino acid synthesized in the body is insufficient, making survival difficult, and abnormal cell division or immobility is caused. can be In a recent study by the present inventors, it was confirmed that ppGpp affects antibiotic sensitivity by regulating the expression of EP (efflux pump)-related genes in A. baumannii , a multidrug-resistant bacterium. suggested that the related A1S_0579 gene could be a target for novel antibiotics (J Antimicrob Chemother. 2020. HW Jung, et al.).
이에, 본 발명자들은 A. baumannii의 항생 물질로서 ppGpp 생합성과 관련된 A1S_0579 유전자의 발현을 저해하는 물질을 탐색하는데 유용한 리포터 균주를 제조함으로써 본 발명을 완성하였다.Accordingly, the present inventors completed the present invention by preparing a reporter strain useful for searching for a substance that inhibits the expression of A1S_0579 gene related to ppGpp biosynthesis as an antibiotic of A. baumannii .
본 발명은 ppGpp 생합성과 관련된 A1S_0579 유전자의 프로모터 부위 및 항생제 저항성 유전자를 포함하는 ppGpp 생합성 관련 유전자 발현 저해물질 탐색용 재조합 플라스미드를 제공하는 것을 목적으로 한다.An object of the present invention is to provide a recombinant plasmid for screening ppGpp biosynthesis-related gene expression inhibitors, which includes the promoter region of the A1S_0579 gene related to ppGpp biosynthesis and an antibiotic resistance gene.
또한, 본 발명은 상기 재조합 플라스미드를 이용한 ppGpp 생합성 관련 유전자 저해물질 탐색용 돌연변이 균주의 제조방법을 제공하는 것을 목적으로 한다.Another object of the present invention is to provide a method for preparing a mutant strain for screening for ppGpp biosynthesis-related gene inhibitors using the recombinant plasmid.
또한, 본 발명은 상기 방법으로 제조된 ppGpp 생합성 관련 유전자 저해물질 탐색용 돌연변이 균주를 제공하는 것을 목적으로 한다.Another object of the present invention is to provide a mutant strain for screening for ppGpp biosynthesis-related gene inhibitors prepared by the above method.
또한, 본 발명은 상기 돌연변이 균주를 이용한 ppGpp 생합성 관련 유전자 저해물질의 탐색 방법을 제공하는 것을 목적으로 한다.Another object of the present invention is to provide a method for screening a ppGpp biosynthesis-related gene inhibitor using the mutant strain.
본 발명의 A1S_0579 유전자는 본 발명자들의 이전 연구 (J Antimicrob Chemother. 2020. HW Jung, et al.)를 통해 ppGpp 생합성과 관련된 것으로 확인되었다. ppGpp는 박테리아에서 이차대사산물의 합성 및 형태분화의 제어에 관여하는 물질로서 박테리아의 생존에 영향을 미치는 중요한 역할을 하는 것이 밝혀졌다. 따라서, ppGpp 생합성과 관련된 A1S_0579 유전자 발현의 저해물질은 해당 박테리아의 감염을 예방하거나 치료하기 위한 물질로서 매우 유용한 가치가 있다고 판단된다.The A1S_0579 gene of the present invention was confirmed to be related to ppGpp biosynthesis through our previous study (J Antimicrob Chemother. 2020. HW Jung, et al.). ppGpp was found to play an important role in affecting the survival of bacteria as a substance involved in the control of the synthesis and morphogenesis of secondary metabolites in bacteria. Therefore, it is judged that the inhibitor of A1S_0579 gene expression related to ppGpp biosynthesis has a very useful value as a material for preventing or treating infection of the corresponding bacteria.
본 발명의 일 양상은 ppGpp 생합성과 관련된 A1S_0579 유전자를 타겟(target)으로 하는 저해물질을 확인, 탐색하기 위해 A1S_0579 유전자의 프로모터 부위 및 항생제 저항성 유전자를 포함하는 ppGpp 생합성 관련 유전자 발현 저해물질 탐색용 재조합 플라스미드를 제공한다.One aspect of the present invention is a recombinant plasmid for ppGpp biosynthesis-related gene expression inhibitors including the promoter region of the A1S_0579 gene and antibiotic resistance gene in order to identify and search for inhibitors targeting the A1S_0579 gene related to ppGpp biosynthesis. provides
상기 A1S_0579 유전자의 프로모터는 서열번호 1로 표시되는 염기서열인 것일 수 있다.The promoter of the A1S_0579 gene may be the nucleotide sequence shown in SEQ ID NO: 1.
본 발명의 일 구체예에 따르면, 상기 ppGpp 생합성 관련 유전자 발현 저해물질 탐색용 재조합 플라스미드는 서열번호 1로 표시되는 염기서열로 이루어진 프로모터; 및 항생제 저항성 유전자가 순차적으로 작동 가능하게 연결된 것일 수 있다.According to one embodiment of the present invention, the recombinant plasmid for screening for the ppGpp biosynthesis-related gene expression inhibitor comprises a promoter consisting of the nucleotide sequence represented by SEQ ID NO: 1; and antibiotic resistance genes may be sequentially operably linked.
본 발명에서 사용된 “프로모터(promoter)”는 이에 작동 가능하게 연결된 유전자의 전사를 허용하고 조절하는 폴리뉴클레오티드 서열을 나타낸다. 프로모터는 RNA 중합효소를 결합시키기 위한 인식 서열 및 전사용 개시 부위 (전사 개시 부위)를 함유한다. 특정 세포 유형 또는 숙주 세포 내에서 타겟 유전자를 발현시키기 위해서는 적합한 기능성 프로모터를 선택해야 한다. 이들은 예를 들면, GenBank와 같은 데이터뱅크에 기탁되어 있으며, 시판되거나 개개의 공급원으로부터 폴리뉴클레오티드 서열 내에 클로닝된 별개의 요소 또는 요소들로서 입수할 수 있다.As used herein, “promoter” refers to a polynucleotide sequence that allows and regulates the transcription of a gene operably linked thereto. A promoter contains a recognition sequence for binding RNA polymerase and an initiation site for transcription (transcription initiation site). In order to express the target gene in a particular cell type or host cell, it is necessary to select a suitable functional promoter. They are deposited in databanks such as, for example, GenBank, and may be commercially available or available as separate elements or elements cloned into polynucleotide sequences from individual sources.
상기 프로모터는 미생물에서 ppGpp 생합성 관련 유전자의 프로모터 부위인 것으로, 상기 미생물은 병원균(pathogenic bacteria)으로서 악티노미세스(Actinomyces) 속, 바실러스(Bacillus) 속, 보렐리아(Borrelia) 속, 클라미디아(Chlamydia) 속, 클로스트리듐(Clostridium) 속, 엔데로코커스(Enterococcus) 속, 에세르시아(Escherichia) 속, 헬리코박터(Helicobacter) 속, 클렙시엘라(Klebsiella) 속, 리지오넬라(Legionella) 속, 미코박테리움(Mycobacterium) 속, 슈도모나스(Pseudomonas) 속, 살모넬라(Salmonella) 속, 시젤라(Shigella) 속, 스타필로코커스(Staphylococcus) 속, 스트렙토코커스(Streptococcus) 속, 비브리오(Vibrio) 속 또는 아시네토박터(Acinetobacter) 속 미생물일 수 있으며, 바람직하게는 아시네토박터 바우마니(Acinetobacter baumannii)일 수 있다.The promoter is a promoter region of a ppGpp biosynthesis-related gene in a microorganism, and the microorganism is a pathogenic bacteria, such as Actinomyces , Bacillus , Borrelia , Chlamydia . , Clostridium genus, Enterococcus genus, Escherichia genus, Helicobacter genus, Klebsiella genus, Legionell a genus, Mycobacterium Mycobacterium genus, Pseudomonas genus, Salmonella genus, Shigell a genus, Staphylococcus genus, Streptococcus genus, Vibrio genus, or Acineto It may be a microorganism of the genus Acinetobacter , preferably Acinetobacter baumannii .
본 발명에서 사용된 "서열번호 1로 표시되는 염기서열로 이루어진 프로모터"는 타겟 유전자인 서열번호 1의 염기서열을 포함하는 A1S_0579 유전자의 유전정보를 지니고 있는 DNA 염기서열 앞부분에 위치하여 유전자의 전사를 조절하는 부위이며, A1S_0579 유전자 프로모터에 작동 가능하게 연결된 유전자는 A1S_0579 유전자 프로모터 부위에 의해 발현이 조절된다. The "promoter consisting of the nucleotide sequence represented by SEQ ID NO: 1" used in the present invention is located in the front part of the DNA nucleotide sequence carrying the genetic information of the A1S_0579 gene including the nucleotide sequence of SEQ ID NO: 1, which is the target gene, and transcription of the gene It is a regulatory region, and the expression of a gene operably linked to the A1S_0579 gene promoter is regulated by the A1S_0579 gene promoter region.
본 발명에서 사용된 "항생제 저항성 유전자"는 당업계의 공지된 항생제 저항성 유전자가 그 발현을 조절하는 프로모터 없이 재조합 플라스미드에 도입되는 것을 의미한다. 구체적으로, 재조합 플라스미드에 도입되는 항생제 저항성 유전자는 ORF(open reading frame) 영역일 수 있다. 상기 서열번호 1의 염기서열로 이루어진 프로모터와 연결된 항생제 저항성 유전자는 서열번호 1의 염기서열로 이루어진 프로모터에 의해 발현이 조절되어 항생제 저항성 유전자의 발현 정도를 쉽게 측정할 수 있기 때문에 본 발명의 재조합 플라스미드에서 리포터 유전자(reporter gene)의 역할을 한다.As used herein, "antibiotic resistance gene" means that an antibiotic resistance gene known in the art is introduced into a recombinant plasmid without a promoter regulating its expression. Specifically, the antibiotic resistance gene introduced into the recombinant plasmid may be an open reading frame (ORF) region. Since the expression of the antibiotic resistance gene linked to the promoter consisting of the nucleotide sequence of SEQ ID NO: 1 is regulated by the promoter consisting of the nucleotide sequence of SEQ ID NO: 1, the expression level of the antibiotic resistance gene can be easily measured in the recombinant plasmid of the present invention. It acts as a reporter gene.
본 발명에서 사용된 "항생제 저항성 유전자"는 항생제에 대하여 저항성을 가지는 유전자로, 이러한 유전자가 있는 세균 또는 미생물은 해당 항생제를 처리한 환경에서도 생존하므로, 본 발명에서 서열번호 1의 염기서열로 이루어진 프로모터에 의해 발현이 조절되는 항생제 저항성 유전자를 포함하는 재조합 플라스미드를 얻는 과정에 선별 마커 (또는 리포터 마커)로 사용된다. The "antibiotic resistance gene" used in the present invention is a gene having resistance to antibiotics, and since bacteria or microorganisms having this gene survive even in an environment treated with the antibiotic, a promoter consisting of the nucleotide sequence of SEQ ID NO: 1 in the present invention It is used as a selection marker (or reporter marker) in the process of obtaining a recombinant plasmid containing an antibiotic resistance gene whose expression is regulated by
상기 항생제 저항성 유전자는 암피실린(ampicilin), 테트라사이클린(tetracyclin), 카나마이신(kanamycin), 클로람페니콜(chloroamphenicol), 스트렙토마이신(streptomycin), 네오마이신(neomycin) 등의 항생제에 대한 저항성 유전자 등을 사용할 수 있으며, 일례로 nptI 유전자, bla 유전자 (ampicillin resistance gene), 또는 cat 유전자 (chloramphenicol resistance gene) 등일 수 있다. 구체적으로, 상기 항생제 저항성 유전자는 nptI 유전자 (서열번호 2)일 수 있다.The antibiotic resistance gene may be a resistance gene against antibiotics such as ampicillin, tetracyclin, kanamycin, chloramphenicol, streptomycin, neomycin, etc., For example, it may be an nptI gene, a bla gene (ampicillin resistance gene), or a cat gene (chloramphenicol resistance gene). Specifically, the antibiotic resistance gene may be an nptI gene (SEQ ID NO: 2).
상기 nptI 유전자는 네오마이신 인산전달효소(Neomycin phosphotransferase) 단백질을 암호화하는 유전자로서 미생물에 카나마이신(kanamycin), 트리메소프림(trimethoprim), 네오마이신(neomycin), 젠타마이신(geneticin), 파로모마이신(paromomycin) 등의 항생제에 대한 저항성을 부여할 수 있다.The nptI gene is a gene encoding a neomycin phosphotransferase protein, and in microorganisms kanamycin, trimethoprim, neomycin, gentamicin, paromomycin ) can confer resistance to antibiotics such as
본 발명에서 사용된 "작동 가능하게 연결된(operably linked)"이란 일반적으로 기능을 수행하도록 유전자의 발현 조절 서열과 타겟 단백질을 코딩하는 염기서열이 작동 가능하게 연결되어 코딩하는 염기서열의 발현에 영향을 미칠 수 있다. 재조합 플라스미드와의 작동 가능한 연결은 당업계의 공지된 유전자 재조합 기술을 이용하여 제조할 수 있으며, 부위-특이적 DNA 절단 및 연결은 당업계의 절단 및 연결 효소 등을 사용하여 제작할 수 있다.As used in the present invention, "operably linked" means that the expression control sequence of a gene and the nucleotide sequence encoding the target protein are operably linked to perform a function in general, thereby affecting the expression of the coding nucleotide sequence. can go crazy An operable linkage with a recombinant plasmid can be prepared using a genetic recombination technique known in the art, and site-specific DNA cleavage and ligation can be made using a cleavage and ligation enzyme in the art.
이러한 ppGpp 생합성 관련 유전자 발현 저해물질 탐색용 재조합 플라스미드는 미생물 안에서 스스로 복제 가능하도록 복제시작점(ori) 및 이를 조절하는 요소(element)를 포함하므로 본 발명자가 도입하고자 하는 서열번호 1의 염기서열로 이루어진 프로모터 및 항생제 저항성 유전자를 포함하는 DNA 단편이 스스로 발현될 수 있다. 이때, 상기 DNA 단편은 미생물 안에 1개 이상의 카피, 즉 다중 카피(multiple copy)의 형태로 존재할 수 있다.Since the recombinant plasmid for searching for ppGpp biosynthesis-related gene expression inhibitors includes a replication origin (ori) and an element regulating it to enable self-replication in microorganisms, the promoter consisting of the nucleotide sequence of SEQ ID NO: 1 to be introduced by the present inventors and a DNA fragment comprising an antibiotic resistance gene can be expressed by itself. In this case, the DNA fragment may exist in the form of one or more copies, that is, multiple copies in the microorganism.
본 발명의 일 구체예에 따른 ppGpp 생합성 관련 유전자 발현 저해물질 탐색용 재조합 플라스미드는 A. baumannii의 서열번호 1로 표시되는 염기서열로 이루어진 프로모터; 및 항생제 저항성 유전자가 순차적으로 연결된 것으로, 서열번호 3으로 표시되는 염기서열을 포함하는 것일 수 있다. 이때, 서열번호 3의 염기서열과 높은 상동성을 갖는 서열, 예를 들면 그 상동성이 70% 이상, 80% 이상, 또는 90% 이상의 상동성을 갖는 서열도 본 발명의 범위에 포함되는 것으로 해석될 수 있다. 이러한 재조합 플라스미드를 이용하여 형질전환체 또는 돌연변이 균주를 제조할 경우, 염색체 내에 도입된 단일 카피(single copy) 또는 다중 카피의 DNA 단편에 의해 항생제 저항성 유전자가 발현된다.A recombinant plasmid for screening ppGpp biosynthesis-related gene expression inhibitors according to an embodiment of the present invention comprises: a promoter consisting of the nucleotide sequence represented by SEQ ID NO: 1 of A. baumannii ; And antibiotic resistance genes are sequentially linked, and may include a nucleotide sequence represented by SEQ ID NO: 3. In this case, a sequence having high homology with the nucleotide sequence of SEQ ID NO: 3, for example, a sequence having 70% or more, 80% or more, or 90% or more homology thereof is also interpreted as being included in the scope of the present invention. can be When a transformant or mutant strain is prepared using such a recombinant plasmid, the antibiotic resistance gene is expressed by a single copy or multiple copies of a DNA fragment introduced into a chromosome.
한편, 본 명세서에서 "DNA 단편", "유전자 단편" 및 "유전자"는 동일한 의미로 혼용되어 사용될 수 있고, "재조합 플라스미드" 및 "재조합 벡터"도 동일한 의미로 혼용되어 사용될 수 있다.Meanwhile, in the present specification, "DNA fragment", "gene fragment" and "gene" may be used interchangeably with the same meaning, and "recombinant plasmid" and "recombinant vector" may be used interchangeably with the same meaning.
본 발명의 다른 일 구체예에 따르면, 상기 ppGpp 생합성 관련 유전자 발현 저해물질 탐색용 재조합 플라스미드는 표적 유전자의 5' 말단과 상동인 핵산 영역; 서열번호 1로 표시되는 염기서열로 이루어진 프로모터; 항생제 저항성 유전자; 및 표적 유전자의 3' 말단과 상동인 핵산 영역이 순차적으로 작동 가능하게 연결된 것일 수 있다.According to another embodiment of the present invention, the recombinant plasmid for screening for the ppGpp biosynthesis-related gene expression inhibitor includes a nucleic acid region homologous to the 5' end of the target gene; a promoter consisting of the nucleotide sequence represented by SEQ ID NO: 1; antibiotic resistance gene; and a nucleic acid region homologous to the 3' end of the target gene may be sequentially operably linked.
본 발명에서 사용된 "표적 유전자"는 상기 재조합 플라스미드를 도입하려는 미생물의 게놈(genome) 내 위치를 의미하며, 구체적으로 상기 표적 유전자의 5'- 및 3'- 말단에 본 발명의 재조합 플라스미드가 도입되어 상기 재조합 플라스미드를 포함하는 돌연변이 균주가 제조될 수 있다. 구체적으로, 상기 표적 유전자는 glmS 유전자일 수 있다."Target gene" as used in the present invention means a location in the genome of a microorganism into which the recombinant plasmid is to be introduced, specifically, the recombinant plasmid of the present invention is introduced at the 5'- and 3'-terminus of the target gene. Thus, a mutant strain containing the recombinant plasmid can be prepared. Specifically, the target gene may be a glmS gene.
본 발명에서 사용된 "표적 유전자의 5' 말단과 상동인 핵산 영역" 및 "표적 유전자의 3' 말단과 상동인 핵산 영역"은 상기 표적 유전자의 각 말단과 상동성을 갖는 핵산 서열을 의미하며, 구체적으로 상동성에 의한 상동재조합을 통해 미생물의 게놈 내 정해진 위치에 본 발명의 재조합 플라스미드를 도입하는 목적의 서열일 수 있다. 상기 표적 유전자의 5' 말단과 상동인 핵산 영역은 서열번호 4로 표시되는 염기서열로 이루어진 것일 수 있고, 표적 유전자의 3' 말단과 상동인 핵산 영역은 서열번호 5로 표시되는 염기서열로 이루어진 것일 수 있다. 이때, 상기 상동성은 70% 이상, 80% 이상, 또는 90% 이상일 수 있으며, 상기 핵산 영역은 500 내지 1,500 bp, 700 내지 1,300 bp, 또는 900 내지 1,100 bp일 수 있다.As used herein, "a nucleic acid region homologous to the 5' end of the target gene" and "a nucleic acid region homologous to the 3' end of the target gene" refer to a nucleic acid sequence having homology with each end of the target gene, Specifically, it may be a sequence for the purpose of introducing the recombinant plasmid of the present invention into a predetermined position in the genome of a microorganism through homologous recombination by homology. The nucleic acid region homologous to the 5' end of the target gene may consist of the nucleotide sequence shown in SEQ ID NO: 4, and the nucleic acid region homologous to the 3' end of the target gene may be composed of the nucleotide sequence shown in SEQ ID NO: 5 can In this case, the homology may be 70% or more, 80% or more, or 90% or more, and the nucleic acid region may be 500 to 1,500 bp, 700 to 1,300 bp, or 900 to 1,100 bp.
상기 서열번호 1로 표시되는 염기서열로 이루어진 프로모터 및 항생제 저항성 유전자는 전술한 바와 동일하다.The promoter and antibiotic resistance gene consisting of the nucleotide sequence represented by SEQ ID NO: 1 are the same as described above.
상기 재조합 플라스미드는 미생물을 선별하기 유전자를 추가로 포함할 수 있으며, 그 유전자로는 cat 유전자일 수 있다. 상기 cat 유전자는 미생물에 항생제인 클로람페니콜(chloramphenicol)에 대한 저항성을 부여하므로, 본 발명에서는 상기 재조합 플라스미드에 포함됨으로써 형질전환된, 돌연변이 균주의 선별 마커로서 사용될 수 있다.The recombinant plasmid may further include a gene for selecting microorganisms, and the gene may be a cat gene. Since the cat gene imparts resistance to the antibiotic chloramphenicol to microorganisms, in the present invention, it can be used as a selection marker for a mutant strain transformed by being included in the recombinant plasmid.
또한, 상기 재조합 플라스미드는 표적 유전자의 3' 말단과 상동인 핵산 영역 뒤에 sacB 유전자를 추가로 포함할 수 있다. 상기 sacB 유전자는 수크로스를 분해하는 효소로 알려진 수크라제(sucrase)를 암호화하는 유전자 (DNA 단편)를 의미한다.In addition, the recombinant plasmid may further include a sacB gene after a nucleic acid region homologous to the 3' end of the target gene. The sacB gene refers to a gene (DNA fragment) encoding sucrase, which is known as an enzyme that degrades sucrose.
구체적으로, 상기 자살 벡터를 포함하는 미생물을 수크로스가 포함된 배지에서 배양하는 경우, 상기 sacB 유전자에 의해 발현된 수크라제는 수크로스를 분해하여 미생물에게 독성을 나타내는 산물을 생성하게 되며, 이는 숙주 미생물의 게놈 DNA에서 단일교차 재조합이 유발되지 않은, 즉 항생제 저항성을 나타내는 미생물이 배제된다. 반면, 숙주 미생물의 게놈 DNA에서 단일교차 재조합이 유발되면, 벡터의 DNA 단편 전체를 포함하는 영역이 미생물의 게놈 DNA에서 제거되어 야생형 다제내성 미생물로 복귀하거나, 또는 벡터의 DNA 단편 중에서도 목적하는 ompA 프로모터와 Rluc8 유전자만을 제외한 영역이 제거될 수 있다.Specifically, when the microorganism containing the suicide vector is cultured in a medium containing sucrose, the sucrose expressed by the sacB gene decomposes sucrose to produce a product that is toxic to the microorganism, which Microorganisms that have not induced single cross recombination in the genomic DNA of the host microorganism, ie, exhibit antibiotic resistance, are excluded. On the other hand, when single cross recombination is induced in the genomic DNA of the host microorganism, the region including the entire DNA fragment of the vector is removed from the genomic DNA of the microorganism to return to the wild-type multidrug-resistant microorganism, or the desired ompA promoter among the DNA fragments of the vector Regions except for and Rluc8 genes can be removed.
이러한 ppGpp 생합성 관련 유전자 발현 저해물질 탐색용 재조합 플라스미드는 자살 벡터(suicide vector 또는 suicide plasmid vector)로서 미생물 안에서 스스로 복제되지 않고, 이에 포함된 유전자, 즉 본 발명자가 도입하고자 하는 서열번호 1의 염기서열로 이루어진 프로모터 및 항생제 저항성 유전자를 포함하는 DNA 단편이 스스로 발현되지 않으나, 상기 DNA 단편이 상동재조합을 통해 미생물의 염색체 내에 삽입되는 경우 목적하는 서열번호 1의 염기서열로 이루어진 프로모터 및 항생제 저항성 유전자만이 삽입되는 것을 특징으로 한다.Recombinant plasmid for searching for ppGpp biosynthesis-related gene expression inhibitors is a suicide vector or suicide plasmid vector, which does not replicate itself in microorganisms, and is a gene included therein, that is, the nucleotide sequence of SEQ ID NO: 1 to be introduced by the present inventors. Although the DNA fragment comprising the promoter and the antibiotic resistance gene is not expressed by itself, when the DNA fragment is inserted into the chromosome of a microorganism through homologous recombination, only the promoter and the antibiotic resistance gene comprising the nucleotide sequence of SEQ ID NO: 1 are inserted characterized by being
본 발명의 다른 일 구체예에 따른 ppGpp 생합성 관련 유전자 발현 저해물질 탐색용 재조합 플라스미드는 표적 유전자의 5' 말단과 상동인 핵산 영역; A. baumannii의 서열번호 1로 표시되는 염기서열로 이루어진 프로모터; 항생제 저항성 유전자; 및 표적 유전자의 3' 말단과 상동인 핵산 영역이 순차적으로 작동 가능하게 연결된 것으로, 서열번호 6으로 표시되는 염기서열을 포함하는 것일 수 있다. 이때, 서열번호 6의 염기서열과 높은 상동성을 갖는 서열, 예를 들면 그 상동성이 70% 이상, 80% 이상, 또는 90% 이상의 상동성을 갖는 서열도 본 발명의 범위에 포함되는 것으로 해석될 수 있다. 이러한 재조합 플라스미드를 이용하여 형질전환체 또는 돌연변이 균주를 제조할 경우, 상기 다중 카피의 벡터를 포함하고 있더라도 염색체 내에 도입된 단일 카피의 DNA 단편에 의해서만 항생제 저항성 유전자가 발현된다. A recombinant plasmid for screening ppGpp biosynthesis-related gene expression inhibitors according to another embodiment of the present invention comprises: a nucleic acid region homologous to the 5' end of a target gene; A promoter consisting of the nucleotide sequence represented by SEQ ID NO: 1 of A. baumannii ; antibiotic resistance gene; and nucleic acid regions homologous to the 3' end of the target gene are sequentially operably linked, and may include the nucleotide sequence represented by SEQ ID NO: 6. In this case, a sequence having high homology with the nucleotide sequence of SEQ ID NO: 6, for example, a sequence having 70% or more, 80% or more, or 90% or more homology thereof is also interpreted as being included in the scope of the present invention. can be When a transformant or a mutant strain is prepared using such a recombinant plasmid, the antibiotic resistance gene is expressed only by the single-copy DNA fragment introduced into the chromosome even if the multi-copy vector is included.
본 발명의 다른 일 양상은 상기 재조합 플라스미드를 미생물에 도입하여 형질전환체를 수득하는 단계를 포함하는 ppGpp 생합성 저해 물질 탐색용 돌연변이 균주의 제조방법을 제공한다.Another aspect of the present invention provides a method for preparing a mutant strain for screening ppGpp biosynthesis inhibitors, comprising the step of obtaining a transformant by introducing the recombinant plasmid into a microorganism.
본 발명의 일 실시예에 따르면, 서열번호 1로 표시되는 염기서열로 이루어진 프로모터 및 항생제 저항성 유전자가 순차적으로 작동 가능하게 연결된 본 발명의 재조합 플라스미드를 미생물에 도입하면, 상기 재조합 플라스미드에 포함된 서열번호 1의 염기서열로 이루어진 프로모터 및 항생제 저항성 유전자가 포함된 DNA 단편이 미생물의 게놈 DNA에 삽입되어 형질전환체로 제조될 수 있다.According to an embodiment of the present invention, when the recombinant plasmid of the present invention is introduced into a microorganism in which a promoter consisting of the nucleotide sequence represented by SEQ ID NO: 1 and an antibiotic resistance gene are sequentially operably linked, SEQ ID NO: A DNA fragment including a promoter consisting of the nucleotide sequence of 1 and an antibiotic resistance gene may be inserted into the genomic DNA of a microorganism to prepare a transformant.
본 발명의 다른 일 실시예에 따르면, 표적 유전자의 5' 말단과 상동인 핵산 영역, 서열번호 1로 표시되는 염기서열로 이루어진 프로모터, 항생제 저항성 유전자 및 표적 유전자의 3' 말단과 상동인 핵산 영역이 순차적으로 작동 가능하게 연결된 본 발명의 재조합 플라스미드 (자살 벡터)를 미생물에 도입하면, 상기 재조합 플라스미드에 포함된 표적 유전자의 5' 말단과 상동인 핵산 영역에 해당하는 glmS 상위 유전자가 1차 단일교차 재조합이 유발되어 상기 재조합 플라스미드에 포함된 DNA 단편 전체가 미생물의 게놈 DNA에 삽입된 형질전환체를 제조할 수 있다. 상기 형질전환체를 일정 시간 배양 시 일정 확률에 따라 2차 단일 교차 재조합이 일어날 수 있다. 상기 형질전환체를 과량의 수크로스가 포함된 배지에 접종하고 배양하면, 2차 단일교차 재조합이 유발되지 아니한 미생물은 재조합 플라스미드에 포함된 sacB 유전자로부터 발현된 수크라제에 의해 수크로스를 분해하고, 이로부터 생성되는 독성산물로 인하여 배제될 수 있다. 상기 2차 단일교차 재조합이 유발되면, 상기 자살 벡터의 DNA 단편 전체를 포함하는 영역이 미생물의 게놈 DNA에서 제거되어 야생형 미생물로 복귀하거나, 또는 재조합 플라스미드의 DNA 단편 중에서도 nptI 유전자만을 포함하는 영역이 제거될 수 있다. According to another embodiment of the present invention, a nucleic acid region homologous to the 5' end of the target gene, a promoter consisting of the nucleotide sequence represented by SEQ ID NO: 1, an antibiotic resistance gene, and a nucleic acid region homologous to the 3' end of the target gene When the recombinant plasmid (suicide vector) of the present invention sequentially operably linked is introduced into a microorganism, the glmS upstream gene corresponding to the nucleic acid region homologous to the 5' terminus of the target gene included in the recombinant plasmid is first single-crossed recombination This can be induced to prepare a transformant in which the entire DNA fragment contained in the recombinant plasmid is inserted into the genomic DNA of the microorganism. When the transformant is cultured for a certain period of time, secondary single crossover recombination may occur according to a certain probability. When the transformant is inoculated in a medium containing an excess of sucrose and cultured, the microorganism in which the second single cross recombination is not induced breaks down the sucrose by sucrose expressed from the sacB gene contained in the recombinant plasmid, and , can be excluded due to toxic products produced therefrom. When the second single crossover recombination is induced, the region containing the entire DNA fragment of the suicide vector is removed from the genomic DNA of the microorganism and returned to the wild-type microorganism, or the region containing only the nptI gene among the DNA fragments of the recombinant plasmid is removed can be
상기 형질전환체의 제조 성공 여부는 nptI 유전자에 의한 항생제 (예를 들면, 카나마이신 및/또는 트리메소프림) 저항성에 의해 확인할 수 있다.Whether or not the production of the transformant was successful may be confirmed by resistance to antibiotics (eg, kanamycin and/or trimethoprim) caused by the nptI gene.
상기 재조합 플라스미드를 미생물에 도입하여 형질전환체를 수득하는 방법은 당업계의 공지된 핵산을 세포 내로 도입하는 방법을 이용할 수 있으며, 숙주 미생물 또는 숙주 세포에 따라 당업계의 공지된 바와 같이 적합한 표준 기술을 선택하여 수행할 수 있다. 예를 들어, 전기천공법(electroporation), 인산칼슘(CaPO4) 침전, 염화칼슘(CaCl2) 침전, 미세주입법(microinjection), 폴리에틸렌글리콜(PEG)법, DEAE-덱스트란(dextran)법, 양이온 리포좀법(cationic liposome), 초산 리튬(Lithium superoxide)-DMSO법 등일 수 있다.A method of introducing the recombinant plasmid into a microorganism to obtain a transformant may use a method of introducing a nucleic acid into a cell known in the art, and a suitable standard technique as known in the art depending on the host microorganism or host cell This can be done by selecting . For example, electroporation, calcium phosphate (CaPO4) precipitation, calcium chloride (CaCl2) precipitation, microinjection, polyethylene glycol (PEG) method, DEAE-dextran method, cationic liposome method ( cationic liposome), lithium superoxide-DMSO method, and the like.
본 발명에서 사용된 "형질전환(transformation)"은 DNA를 숙주로 도입하여 DNA가 염색체외 인자로서 또는 염색체 통합완성에 의해 복제 가능하게 되는 것을 의미한다. 본 발명에서 사용된 "형질전환체(transformant)"는 플라스미드 또는 벡터가 숙주 세포 내로 형질전환된 후, 벡터 내의 서열번호 1의 염기서열로 이루어진 프로모터 및 항생제 저항성 유전자를 포함하는 핵산 분자 서열이 숙주 세포 게놈 상의 내생적(endogeneous) 유전자 부위의 서열과 상동 재조합을 일으키며 염색체 내로 삽입되거나, 플라스미드 형태로 보유할 수 있다.As used in the present invention, "transformation (transformation)" means introducing DNA into a host so that the DNA becomes replicable as an extrachromosomal factor or by chromosomal integration completion. As used in the present invention, "transformant" refers to a nucleic acid molecule sequence comprising a promoter consisting of the nucleotide sequence of SEQ ID NO: 1 in the vector and an antibiotic resistance gene after the plasmid or vector is transformed into a host cell. It undergoes homologous recombination with the sequence of an endogenous gene region on the genome and may be inserted into a chromosome or retained in the form of a plasmid.
또한, 본 발명의 다른 일 양상은 상기 방법으로 제조된 ppGpp 생합성 관련 유전자 저해물질 탐색용 돌연변이 균주를 제공한다.In addition, another aspect of the present invention provides a mutant strain for screening ppGpp biosynthesis-related gene inhibitors prepared by the above method.
본 발명의 일 실시예에 따르면, 상기 재조합 플라스미드로 형질전환된 돌연변이 균주는 리포터 균주(reporter strain)로서 카나마이신 항생제 저항성 유전자 (nptI)가 서열번호 1의 염기서열로 이루어진 프로모터에 의해 조절되기 때문에 카나마이신 존재 환경에서 성장이 가능한 반면, 재조합 플라스미드를 갖고 있지 않은 균주는 성장하지 못하였다. 이는 재조합 플라스미드 내에 존재하는 항생제 저항성 유전자 nptI가 A. baumannii의 ppGpp 생합성 관련 A1S_0579 유전자의 발현 조절 시스템에 의해 조절됨을 의미한다. 따라서 본 발명에서 구축된 리포터 균주는 A1S_0579 유전자의 발현 저해물질을 고속대량으로 탐색하는데 유용하게 사용될 수 있다.According to one embodiment of the present invention, the mutant strain transformed with the recombinant plasmid is a reporter strain, and the kanamycin antibiotic resistance gene (nptI) is regulated by the promoter consisting of the nucleotide sequence of SEQ ID NO: 1, so the presence of kanamycin While growth was possible in the environment, strains without recombinant plasmid did not grow. This means that the antibiotic resistance gene nptI present in the recombinant plasmid is regulated by the expression control system of the A1S_0579 gene related to the ppGpp biosynthesis of A. baumannii . Therefore, the reporter strain constructed in the present invention can be usefully used for high-speed and large-scale screening of A1S_0579 gene expression inhibitors.
또한, 본 발명의 다른 일 양상은 a) 항생제가 포함된 고체배지에서 상기 돌연변이 균주를 배양하는 단계; 및 b) 상기 돌연변이 균주에 시험물질을 접촉시키는 단계를 포함하는 ppGpp 생합성 관련 유전자 저해물질의 탐색 방법을 제공한다.In addition, another aspect of the present invention comprises the steps of: a) culturing the mutant strain in a solid medium containing antibiotics; And b) provides a screening method for a ppGpp biosynthesis-related gene inhibitor comprising the step of contacting the test substance with the mutant strain.
상기 a) 단계의 항생제는 재조합 플라스미드에 도입된 항생제 저항성 유전자가 저항성을 나타내는 항생제로서 카나마이신(kanamycin), 트리메소프림(trimethoprim), 네오마이신(neomycin), 젠타마이신(geneticin; G418), 파로모마이신(paromomycin) 등일 수 있으며, 바람직하게는 카나마이신일 수 있다.The antibiotic of step a) is an antibiotic that exhibits resistance to the antibiotic resistance gene introduced into the recombinant plasmid, and includes kanamycin, trimethoprim, neomycin, gentamicin (G418), paromomycin. (paromomycin) and the like, preferably kanamycin.
이러한 ppGpp 생합성 유전자 관련 저해물질의 탐색 방법은 시험물질이 ppGpp 생합성 관련 유전자의 발현을 저해하는 저해물질일 경우, ppGpp 생합성 관련 유전자의 프로모터에 의해 발현이 조절되는 항생제 저항성 유전자가 발현되지 못하기 때문에 해당 항생제가 포함된 고체배지에서 돌연변이 균주가 성장할 수 없다. 그러므로, 시험물질에 의해 상기 돌연변이 균주가 성장하지 못하는 경우에는 접촉된 후보물질을 ppGpp 생합성 관련 유전자의 발현 저해물질로 판단할 수 있다. 따라서, 본 발명에 따른 탐색 방법은 간편하게 해당 균주의 성장을 측정하여 ppGpp 생합성 관련 유전자의 발현 저해물질을 탐색할 수 있는 장점이 있다.This ppGpp biosynthesis gene-related inhibitor screening method is applicable because, when the test substance is an inhibitor that inhibits the expression of ppGpp biosynthesis-related genes, the antibiotic resistance gene whose expression is regulated by the promoter of the ppGpp biosynthesis-related gene cannot be expressed. Mutant strains cannot grow on a solid medium containing antibiotics. Therefore, when the mutant strain cannot be grown by the test substance, the contacted candidate substance can be judged as an expression inhibitor of the ppGpp biosynthesis-related gene. Therefore, the screening method according to the present invention has the advantage of being able to search for inhibitors of the expression of ppGpp biosynthesis-related genes by simply measuring the growth of the corresponding strain.
본 발명에 따른 ppGpp 생합성 관련 유전자 발현 저해물질 탐색용 재조합 플라스미드 및 돌연변이 균주는 ppGpp 생합성 관련 유전자의 프로모터 부위와 항생제 저항성 유전자를 포함함으로써 ppGpp 생합성 관련 유전자의 프로모터에 의해 항생제 저항성 유전자 발현이 조절되고, 상기 돌연변이 균주를 이용한 저해물질 탐색 과정에서 항생제가 첨가된 배지에서 균의 성장을 측정함으로써 ppGpp 생합성 관련 유전자 발현의 저해물질을 손쉽게 탐색할 수 있다.The recombinant plasmid and mutant strain for screening ppGpp biosynthesis-related gene expression inhibitors according to the present invention include the promoter region of the ppGpp biosynthesis-related gene and the antibiotic resistance gene. Inhibitors of ppGpp biosynthesis-related gene expression can be easily searched for by measuring the growth of bacteria in an antibiotic-added medium in the process of searching for inhibitors using mutant strains.
도 1은 본 발명의 일 실시예에 따른 재조합 플라스미드 pWH1266_A1S0579p-nptⅠ의 개발 모식도이다.
도 2는 본 발명의 일 실시예에 따른 재조합 플라스미드 pWH1266_A1S0579p-nptⅠ의 A1S_0579 프로모터 부위 및 nptⅠ의 DNA 시퀀싱을 통해 도입 유전자들을 확인한 결과이다.
도 3은 본 발명의 일 실시예에 따른 재조합 플라스미드 pDM4_A1S0579p-nptⅠ의 개발 모식도이다.
도 4는 본 발명의 일 실시예에 따른 재조합 플라스미드 pDM4_A1S0579p-nptⅠ의 A1S_0579 프로모터 부위 및 nptⅠ의 DNA 시퀀싱을 통해 도입 유전자들을 확인한 결과이다.
도 5는 본 발명의 일 실시예에 따른 (A) 야생형 균주 및 재조합 플라스미드 (B) pWH1266_A1S0579p-nptⅠ로 형질전환된 돌연변이 균주에 대한 카나마이신 항생제 첨가된 배지에서의 성장 여부를 확인한 결과이다.
도 6은 본 발명의 일 실시예에 따른 (A) 야생형 균주 및 재조합 플라스미드 (B) pDM4_A1S0579p-nptI로 유전자 삽입된 돌연변이 균주에 대한 카나마이신 항생제 첨가된 배지에서의 성장 여부를 확인한 결과이다.1 is a schematic diagram of the development of a recombinant plasmid pWH1266_A1S0579p-nptI according to an embodiment of the present invention.
2 shows the results of confirming the transgenes through DNA sequencing of the A1S_0579 promoter region and nptI of the recombinant plasmid pWH1266_A1S0579p-nptI according to an embodiment of the present invention.
3 is a schematic diagram of the development of a recombinant plasmid pDM4_A1S0579p-nptI according to an embodiment of the present invention.
4 shows the results of confirming the transgenes through DNA sequencing of the A1S_0579 promoter region and nptI of the recombinant plasmid pDM4_A1S0579p-nptI according to an embodiment of the present invention.
5 is a result of confirming whether growth in a medium containing kanamycin antibiotics for a mutant strain transformed with (A) a wild-type strain and a recombinant plasmid (B) pWH1266_A1S0579p-nptI according to an embodiment of the present invention.
6 is a result of confirming whether growth in a medium containing kanamycin antibiotics for (A) wild-type strain and recombinant plasmid (B) pDM4_A1S0579p-nptI gene-inserted mutant strain according to an embodiment of the present invention.
이하, 본 발명을 보다 상세하게 설명한다. 그러나, 이러한 설명은 본 발명의 이해를 돕기 위하여 예시적으로 제시된 것일 뿐, 본 발명의 범위가 이러한 예시적인 설명에 의하여 제한되는 것은 아니다.Hereinafter, the present invention will be described in more detail. However, these descriptions are provided for illustrative purposes only to help the understanding of the present invention, and the scope of the present invention is not limited by these illustrative descriptions.
실시예 1. A1S_0579-nptⅠ의 제조 Example 1. Preparation of A1S_0579-nptI
1-1. pWH1266_A1S0579p-nptⅠ 재조합 플라스미드 제조1-1. pWH1266_A1S0579p-nptⅠ recombinant plasmid preparation
pWH1266 플라스미드에 클로닝 하기 위하여, A1S_0579 프로모터 부위와 nptⅠ (kanamycin 항생제 저항성 유전자)를 Overlap extension PCR을 통하여 연결시켜 주었다. 이때, PCR에는 하기 표 1의 프라이머를 사용하였다. 상기 재조합 유전자의 각 양 끝에는 PstⅠ이 인지하는 염기서열 CTGCAG을 추가하여 상기 재조합 유전자에 PstI를 처리한 후 동일한 제한효소로 처리된 pWH1266 플라스미드에 라이게이션(ligation)하여 클로닝하였다. 상기 재조합 플라스미드 맵을 도 1에 나타내었다. 새롭게 구축된 플라스미드는 DNA 시퀀싱을 통하여 확인하였다. 시퀀싱 결과는 도 2에 나타내었다. For cloning into the pWH1266 plasmid, the A1S_0579 promoter region and nptI (kanamycin antibiotic resistance gene) were linked through overlap extension PCR. In this case, the primers in Table 1 below were used for PCR. At each end of the recombinant gene, the base sequence CTGCAG recognized by PstI was added, and the recombinant gene was treated with PstI, and then cloned by ligation to the pWH1266 plasmid treated with the same restriction enzyme. The recombinant plasmid map is shown in FIG. 1 . The newly constructed plasmid was confirmed through DNA sequencing. The sequencing results are shown in FIG. 2 .
(서열번호)primer
(SEQ ID NO:)
(서열번호 7)GlmS_Up_F_speⅠ
(SEQ ID NO: 7)
(서열번호 8)GlmS_Up_R
(SEQ ID NO: 8)
(서열번호 9)A1S_0579p_F
(SEQ ID NO: 9)
(서열번호 10)A1S_0579p_R
(SEQ ID NO: 10)
(서열번호 11)NptⅠ_F
(SEQ ID NO: 11)
(서열번호 12)NptⅠ_R
(SEQ ID NO: 12)
(서열번호 13)GlmS_Down_F
(SEQ ID NO: 13)
(서열번호 14)GlmS_Down_R_ApaⅠ
(SEQ ID NO: 14)
(서열번호 15)A1S_0579p_F_pstⅠ
(SEQ ID NO: 15)
(서열번호 16)NptⅠ_R_pstⅠ
(SEQ ID NO: 16)
1-2. pDM4_A1S0579p-nptⅠ 재조합 플라스미드 제조1-2. Preparation of pDM4_A1S0579p-nptI recombinant plasmid
pDM4 플라스미드에 클로닝 하기 위하여, GlmS 상위(up) 부위, A1S_0579 프로모터 부위, nptⅠ, GlmS 하위(down) 부위를 순서대로 Overlap extension PCR을 통하여 연결시켜 주었다. 상기 재조합 유전자의 각 양 끝에는 SpeⅠ과 ApaⅠ을 인지하는 염기서열 ACTAGT 및 GGGCCC을 추가하여 상기 재조합 유전자에 SpeⅠ과 ApaⅠ을 처리한 후 동일한 제한효소로 처리된 pDM4 플라스미드에 라이게이션하여 클로닝하였다. 상기 재조합 플라스미드 맵을 도 3에 나타내었다. 새롭게 구축된 플라스미드는 DNA 시퀀싱을 통하여 확인하였다. 시퀀싱 결과는 도 4에 나타내었다.In order to clone into the pDM4 plasmid, the GlmS up (up) region, the A1S_0579 promoter region, nptI, and the GlmS down (down) region were ligated in order through overlap extension PCR. At each end of the recombinant gene, ACTAGT and GGGCCC recognizing SpeI and ApaI were added, and the recombinant gene was treated with SpeI and ApaI, and then ligated to the pDM4 plasmid treated with the same restriction enzyme and cloned. The recombinant plasmid map is shown in FIG. 3 . The newly constructed plasmid was confirmed through DNA sequencing. The sequencing results are shown in FIG. 4 .
실시예 2. ppGpp 합성 저해물질 탐색용 리포터 균주의 제조Example 2. Preparation of reporter strains for screening ppGpp synthesis inhibitors
2-1. Multi-copy 리포터 균주 제작 (pWH1266_A1S0579p-nptⅠ 도입)2-1. Multi-copy reporter strain production (pWH1266_A1S0579p-nptⅠ introduced)
상기 실시예 1-1에서 제조된 재조합 플라스미드 pWH1266_A1S0579p-nptⅠ는 전기천공법(electroporation)을 통해 A. baumannii ATCC 17978 Wild-type 세포내로 형질전환 시켰다. 형질전환된 A. baumannii는 카나마이신 (50 μg/ml) 항생제가 첨가된 LB(Luria Bertani) 고체배지에서 선별하였다. 상기 선별 과정을 통해 구축된 리포터 균주(reporter strain)가 갖고 있는 카나마이신 항생제 저항성 유전자(nptI)가 A1S_0579 프로모터에 의해 조절이 되는지 확인하였다.The recombinant plasmid pWH1266_A1S0579p-nptI prepared in Example 1-1 was transformed into
그 결과, 도 5를 참조하면, 재조합 플라스미드 pWH1266_A1S0579p-nptⅠ가 도입되지 않은 A. baumannii는 카나마이신이 첨가된 배지에서 성장하지 못하였으나, pWH1266_A1S0579p-nptⅠ가 도입된 A. baumannii는 카나마이신이 첨가된 배지에서 성장한 것으로 확인되었다. 이러한 결과는 pWH1266_A1S0579p-nptⅠ 내에 존재하는 카나마이신 저항성 유전자 (nptI)가 A. baumannii의 A1S_0579 유전자 발현 조절 시스템에 의하여 조절된다는 것을 시사한다.As a result, referring to FIG. 5 , A. baumannii without recombinant plasmid pWH1266_A1S0579p-nptI did not grow in the medium to which kanamycin was added, but A. baumannii into which pWH1266_A1S0579p-nptI was introduced was grown in the medium to which kanamycin was added. was confirmed to be These results suggest that the kanamycin resistance gene (nptI) present in pWH1266_A1S0579p-nptI is regulated by the A1S_0579 gene expression regulation system of A. baumannii .
2-2. Single-copy 리포터 균주 제작 (pDM4_A1S0579p-nptⅠ 도입)2-2. Single-copy reporter strain production (introduced pDM4_A1S0579p-nptⅠ)
상기 실시예 1-2에서 제조된 재조합 플라스미드 pDM4_A1S0579p-nptⅠ 자살 벡터는 R6K 자살 벡터의 복제를 가능하게 하는 λ pir 가 존재는 공여 균주(Donor strain)인 E. coli SM10 λ pir (thi thr leu tonA lacY supE recA::RP4-2-Tc::Mu Km λ pir)에 형질전환 시켰다. 형질전환된 E. coli SM10 λ pir는 항생제 클로람페니콜 (20 μg/ml)이 첨가된 LB(Luria Bertani) 고체배지에서 선별하였다. 선별된 E. coli SM10 λ pir pDM4_A1S0579p-nptⅠ를 공여체 균주로, A. baumannii ATCC 17978 Wild-type을 수용체 균주로 하여 pDM4_A1S0579p-nptⅠ을 컨주게이션(conjugation)을 통해 상기 재조합 플라스미드를 형질전환 시켰다. 형질전환된 A. baumannii는 카나마이신 (50 μg/ml) 및 트리메토프림 (10 μg/ml) 항생제가 첨가된 LB(Luria Bertani) 고체배지에서 선별하였다. 선별된 균주는 카나마이신 (50 μg/ml) 항생제 및 10% 수크로스(Sucrose)가 첨가된 첨가된 LB(Luria Bertani) 고체배지에서 선별하였다. 상기 선별 과정을 통해 구축된 돌연변이 리포터 균주(reporter strain)가 갖고 있는 카나마이신 항생제 저항성 유전자(nptI)가 A1S_0579 프로모터에 의해 조절이 되는지 확인하였다.The recombinant plasmid pDM4_A1S0579p-nptI suicide vector prepared in Example 1-2 is an E. coli SM10 λ pir (thi thr leu tonA lacY) donor strain with λ pir that enables replication of the R6K suicide vector. supE recA::RP4-2-Tc::Mu Km λ pir) was transformed. Transformed E. coli SM10 λ pir was selected in LB (Luria Bertani) solid medium to which the antibiotic chloramphenicol (20 μg/ml) was added. The recombinant plasmid was transformed through conjugation with the selected E. coli SM10 λ pir pDM4_A1S0579p-nptI as the donor strain and the
그 결과, 도 6을 참조하면, 재조합 플라스미드 pDM4_A1S0579p-nptⅠ가 도입되지 않은 A. baumannii는 카나마이신이 첨가된 배지에서 성장하지 못하였으나, pDM4_A1S0579p-nptⅠ가 도입된 A. baumannii는 카나마이신이 첨가된 배지에서 성장한 것으로 확인되었다. 이러한 결과는 pDM4_A1S0579p-nptⅠ 내에 존재하는 카나마이신 저항성 유전자 (nptI)가 A. baumannii의 A1S_0579 유전자 발현 조절 시스템에 의하여 조절된다는 것을 시사한다.As a result, referring to FIG. 6 , A. baumannii without recombinant plasmid pDM4_A1S0579p-nptI did not grow in the medium to which kanamycin was added, but A. baumannii into which pDM4_A1S0579p-nptI was introduced was grown in the medium to which kanamycin was added. was confirmed to be These results suggest that the kanamycin resistance gene (nptI) present in pDM4_A1S0579p-nptI is regulated by the A1S_0579 gene expression regulation system of A. baumannii .
이제까지 본 발명에 대하여 그 바람직한 실시예들을 중심으로 살펴보았다. 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자는 본 발명이 본 발명의 본질적인 특성에서 벗어나지 않는 범위에서 변형된 형태로 구현될 수 있음을 이해할 수 있을 것이다. 그러므로 개시된 실시예들은 한정적인 관점이 아니라 설명적인 관점에서 고려되어야 한다. 본 발명의 범위는 전술한 설명이 아니라 특허청구범위에 나타나 있으며, 그와 동등한 범위 내에 있는 모든 차이점은 본 발명에 포함된 것으로 해석되어야 할 것이다.So far, with respect to the present invention, the preferred embodiments have been looked at. Those of ordinary skill in the art to which the present invention pertains will understand that the present invention may be implemented in a modified form without departing from the essential characteristics of the present invention. Therefore, the disclosed embodiments are to be considered in an illustrative rather than a restrictive sense. The scope of the present invention is indicated in the claims rather than the foregoing description, and all differences within the scope equivalent thereto should be construed as being included in the present invention.
<110> Kyungpook National University Industry-Academic Cooperation Foundation <120> Recombinant plasmids and mutant strains for screening inhibitors of ppGpp biosynthesis-related gene expression <130> PN200045 <160> 16 <170> KoPatentIn 3.0 <210> 1 <211> 399 <212> DNA <213> Artificial Sequence <220> <223> A1S_0579 Promoter <400> 1 gcaagtgaag aaatggtgca gcgggcaaca gataatgcaa agcgtaataa tctggtgcaa 60 gcaagcttct tttcacaaga tttaacaaaa gatttttcgc atcattcttg ggcaaatcaa 120 ggatttgatg cattattgat tgatcctcct cgtgctggtg catatgaaat tatgcagtat 180 gtgccgaact ttggagcaaa aagaatcgtt tatgtatcat gtaatccagc aacattagca 240 agggatgcag gtgttttggt tcaacatggt taccagttaa aaaaagcagc ggttatggac 300 atgtttacgc acacagaaca tgttgaatcg attgctttat ttgagaaaat tcaagagata 360 aacgattaaa aacatgagtt acatatccag gagaatggt 399 <210> 2 <211> 1095 <212> DNA <213> Artificial Sequence <220> <223> npt I <400> 2 atgagccata ttcaacggga aacgtcttgc tcgaggccgc gattaaattc caacatggat 60 gctgatttat atgggtataa atgggctcgc gataatgtcg ggcaatcagg tgcgacaatc 120 tatcgattgt atgggaagcc cgatgcgcca gagttgtttc tgaaacatgg caaaggtagc 180 gttgccaatg atgttacaga tgagatggtc agactaaact ggctgacgga atttatgcct 240 cttccgacca tcaagcattt tatccgtact cctgatgatg catggttact caccactgcg 300 atccccggga aaacagcatt ccaggtatta gaagaatatc ctgattcagg tgaaaatatt 360 gttgatgcgc tggcagtgtt cctgcgccgg ttgcattcga ttcctgtttg taattgtcct 420 tttaacagcg atcgcgtatt tcgtctcgct caggcgcaat cacgaatgaa taacggtttg 480 gttgatgcga gtgattttga tgacgagcgt aatggctggc ctgttgaaca agtctggaaa 540 gaaatgcata agcttttgcc attctcaccg gattcagtcg tcactcatgg tgatttctca 600 cttgataacc ttatttttga cgaggggaaa ttaataggtt gtattgatgt tggacgagtc 660 ggaatcgcag accgatacca ggatcttgcc atcctatgga actgcctcgg tgagttttct 720 ccttcattac agaaacggct ttttcaaaaa tatggtattg ataatcctga tatgaataaa 780 ttgcagtttc atttgatgct cgatgagttt ttctaatcag aattggttaa ttggttgtaa 840 cactggcaga gcattacgct gacttgacgg gacggcggct ttgttgaata aatcgaactt 900 ttgctgagtt gaaggatcag atcacgcatc ttcccgacaa cgcagaccgt tccgtggcaa 960 agcaaaagtt caaaatcacc aactggtcca cctacaacaa agctctcatc aaccgtggct 1020 ccctcacttt ctggctggat gatggggcga ttcaggcctg gtatgagtca gcaacacctt 1080 cttcacgagg cagac 1095 <210> 3 <211> 10411 <212> DNA <213> Artificial Sequence <220> <223> pWH1266_A1S0579p-npt I <400> 3 ttctcatgtt tgacagctta tcatcgataa gctttaatgc ggtagtttat cacagttaaa 60 ttgctaacgc agtcaggcac cgtgtatgaa atctaacaat gcgctcatcg tcatcctcgg 120 caccgtcacc ctggatgctg taggcatagg cttggttatg ccggtactgc cgggcctctt 180 gcgggatatc gtccattccg acagcatcgc cagtcactat ggcgtgctgc tagcgctata 240 tgcgttgatg caatttctat gcgcacccgt tctcggagca ctgtccgacc gctttggccg 300 ccgcccagtc ctgctcgctt cgctacttgg agccactatc gactacgcga tcatggcgac 360 cacacccgtc ctgtggatcc tctacgccgg acgcatcgtg gccggcatca ccggcgccac 420 aggtgcggtt gctggcgcct atatcgccga catcaccgat ggggaagatc gggctcgcca 480 cttcgggctc atgagcgctt gtttcggcgt gggtatggtg gcaggccccg tggccggggg 540 actgttgggc gccatctcct tgcatgcacc attccttgcg gcggcggtgc tcaacggcct 600 caacctacta ctgggctgct tcctaatgca ggagtcgcat aagggagagc gtcgaccgat 660 gcccttgaga gccttcaacc cagtcagctc cttccggtgg gcgcggggca tgactatcgt 720 cgccgcactt atgactgtct tctttatcat gcaactcgta ggacaggtgc cggcagcgct 780 ctgggtcatt ttcggcgagg accgctttcg ctggagcgcg acgatgatcg gcctgtcgct 840 tgcggtattc ggaatcttgc acgccctcgc tcaagccttc gtcactggtc ccgccaccaa 900 acgtttcggc gagaagcagg ccattatcgc cggcatggcg gccgacgcgc tgggctacgt 960 cttgctggcg ttcgcgacgc gaggctggat ggccttcccc attatgattc ttctcgcttc 1020 cggcggcatc gggatgcccg cgttgcaggc catgctgtcc aggcaggtag atgacgacca 1080 tcagggacag cttcaaggat cgctcgcggc tcttaccagc ctaacttcga tcattggacc 1140 gctgatcgtc acggcgattt atgccgcctc ggcgagcaca tggaacgggt tggcatggat 1200 tgtaggcgcc gccctatacc ttgtctgcct ccccgcgttg cgtcgcggtg catggagccg 1260 ggccacctcg acctgaatgg aagccggcgg cacctcgcta acggattcac cactccaaga 1320 attggagcca atcaattctt gcggagaact gtgaatgcgc aaaccaaccc ttggcagaac 1380 atatccatcg cgtccgccat ctccagcagc cgcacgcggc gcatctcggg cagcgttggg 1440 tcctggccac gggtgcgcat gatcgtgctc ctgtcgttga ggacccggct aggctggcgg 1500 ggttgcctta ctggttagca gaatgaatca ccgatacgcg agcgaacgtg aagcgactgc 1560 tgctgcaaaa cgtctgcgac ctgagcaaca acatgaatgg tcttcggttt ccgtgtttcg 1620 taaagtctgg aaacgcggaa gtcagcgccc tgcaccatta tgttccggat ctgcatcgca 1680 ggatgctgct ggctaccctg tggaacacct acatctgtat taacgaagcg ctggcattga 1740 ccctgagtga tttttctctg gtcccgccgc atccataccg ccagttgttt accctcacaa 1800 cgttccagta accgggcatg ttcatcatca gtaacccgta tcgtgagcat cctctctcgt 1860 ttcatcggta tcattacccc catgaacaga aatccccctt acacggaggc atcagtgacc 1920 aaacaggaaa aaaccgccct taacatggcc cgctttatca gaagccagac attaacgctt 1980 ctggagaaac tcaacgagct ggacgcggat gaacaggcag acatctgtga atcgcttcac 2040 gaccacgctg atgagcttta ccgcagctgc tgctgttgct gctgttcaag tgtcaattgc 2100 tctactctgt tgctcgtctc aatgatagac atatcaagcc tttcagcttt tttattgcgc 2160 tttttgattt catcattacg cttgacgatc tccagttcct cccccctgcg cttggcgtgg 2220 gtggcttcaa gtccctcctt gaatgtcggc tcgatgtcta gtccacgatc cttatgactg 2280 cggtgatcaa ctctcacctc aagccctgct cgctctaggt ggacgttcgt cagatccgcc 2340 actttttccc tgattttttt cagcgttgag ttctgatcta gctccctgac tttcttccct 2400 agcccttgcg gtgtaaggct tcttgttgtc attagtatgt gggcgtgatg gtttctttca 2460 tcacttcccc catgcacatg aggggcatgg atcgctacgt ccaccgccac tccataggct 2520 ttaactaagg actggcacaa ctcggtaaca agtgcctgac gctgtgtctt atccagttca 2580 tgcggcaatg ctatctctac ttcctttgct aatcttgcct cctgtttgat gtcaccgttc 2640 ttttttagtt cggattgctc tacccgattc catagggttt gacgatctaa catgtcagga 2700 cttgccccag ttggggcaaa aatttgggtg tattcaatgc ctgttttttt ggtgtagtcc 2760 tgctcttttc cgtacgtatc acagtacaat ttttcgcctg ctcggtatgc tgcacatgcc 2820 acgattgagc gaccatctga cctcgaaatg ttctgcattt cacaatggta aattgccatt 2880 ttcatcacct gtttattaac agccgcccca agttttgggc ggttggggtg tcggggtttc 2940 cctgaccgta cttgcaaaat ttggcgtagc aaaaattttg cgtaagtgcg cccttcggga 3000 actctgcgag gctaaaagca aaagcaagag caataaggct ttgactttgt tttttgattt 3060 tgctcgctgc gctcggatct tgatgtaagt cgagtttttg aagtagaaca cttttcacat 3120 tgatgatggt tcatacttcg gaaaataggt tgagacacag gcattaaaaa tggtcaaaaa 3180 aacagctatg gaattgggtc aaatgctcga tgaagaaaag gaaaaattgg aacgtcagga 3240 aaaggcaaga aaggatctag ctgacgctgt ggtgaaaggt cgagagcaaa aacaggcaag 3300 gtcagacgat gcaaaacgca agatcctgat cggggcttac ttactgaaga aacatgataa 3360 tgacatcaag aaacttgtgg aacaaaaccc cgattttatt gggtacatta gagaaaatga 3420 taagcactta ttttcatagg cattagtagt tataaaaaac cctcataaat cgagggtttc 3480 ttttttatct gcattacttt ttgaatcaat gtactttttt agcttgctat ttttcactgc 3540 atacagccgc ttatactctt tctcaatcaa tgcggtcaaa atggcttttt ggctctcccc 3600 tgctgcgccc accatgtccg caagcatatc cgacacaccc ttatctataa acacctccaa 3660 acgttgacta tcaaggcttt tgcgtttttc acgatatgct ttttgtcgtt cggcattggt 3720 ttttggcggc tcttttagca tgtcctgtgt tttctgatcg ttcgggtctt tcatgtcttt 3780 aactcccata tagtatatca tagttacagg ataacattgt ttttagttac aggataactt 3840 tttataaaat ttatttgtaa aaatttatgc tatcctgcaa ctatttttaa attacaggat 3900 aactatttaa cgttaccctg taactatagt tatcctgtaa cgctaaatta attaccctgt 3960 aacatatatt ttgttatcct gtaacaacta aatattgaaa taatactacc aaagttaccc 4020 tgtaacgaaa ataactaggt taaaaaatga tcggatttta acattttgcg ttgttccaaa 4080 agttatcaac agcctagaac gtcataggaa gcgattacag acactttata gctatcagca 4140 tgggaacata agggcaggat gaaatatggg tcttaaaacg caaatggtga ggttttagag 4200 gtattttttg aagatgatta aggcggtttg tttttaaaat ttttggcggc tctcaggctg 4260 cttacatttt aaccagttca gtgaaaagtt ctttttcagc aaatttctgt ttagcaccat 4320 agctaaaact tgcgtggaac atattaagaa ttgaccgaaa tgacacaatc tcaattatat 4380 tttttttgaa aagttttctt tatcaaatat tttaaatcat tgatttatat ataagtatac 4440 attcatttta ataattaatc tttatttaac aatgatttat ctatattcaa ttgtttaatt 4500 attcttacta atattatctc tatatcaata ttttttattt aaaaacatat gtttagtagt 4560 gcttttgatt aaagtaccag agggagggag cagagctgaa tgggaaatac tcaccctaga 4620 gcgattctta aaaatcaccc taaagtattc ccattcgatg taccgtcggt cggtcgcttt 4680 cgcatcaggg atgacatcac tgtatcaagc tgccactgtt atgattacga ttgatagcac 4740 cgcctgaaca cgctcataac cgccaattaa atgactactc attgcgtccg ctactctgtt 4800 cagttcccct agtaatagcg tttttccgat gtgtgctagc gtcactgtac ctcatcaccc 4860 acacatggac agattgagtt acagacattg gctaaatttt tggggtctat gcttgacaaa 4920 gcgagttaaa accttagaat ttaagacagg tacattaagc ccctgtggtg aaatcattag 4980 cggtcgtcaa accttaatgc tttcgattgc cgatatgtca gtatcgaaga tctgtacccc 5040 ataaattacg gtaaagcccc aagcaattgc aaggggcttt tatctttttt aacaaaaaaa 5100 atttataaat caggatttta taacactaaa taatccaaag tacatgagta agtcatgacc 5160 actcctgcga tgtgtgtagc actctgagta tccgtattat atcagtgatg tcatatacaa 5220 ccacataatg cggatgtatc actaactccc tagtatcttt ctgtctgcct gtgcgcccca 5280 tcagtcgatt atcaacaact aaatctgtct tttcttcaat taaatcatca atttcaatag 5340 ctgctatagg gttgcgttct tcaagataat catagatatt tctacgatct tggcgagctg 5400 tttcagtcca ctcaatcttc attcttcgct gccagtttcg ccaatgttgc agcacgtcta 5460 gcggcaaact ctgcctttac gtcctcatgt ggaatcaact tgcctgcatt ggcttcattt 5520 aagccgatct gtacctgctg cttgaaccat ttgtcatagt ctgcggcttc ctgttgcttc 5580 ttaacaaagt cacgcatgaa gtcacggatt agctgcgccc ccgaccgatc aacagtctta 5640 gcaaggcttg aaaattcttg ctttaggtca tggtctaccc gaaaggtaaa agtcgcttct 5700 gtcatgtttt tcactccaat gtgttacatt tgaatgctat tgtaacacat taaaaagtta 5760 ggtcattgtc ttttttcggc ttaggctgtt cttggtcata acgtggttta aatgatggct 5820 gtcgctcatt ctcaagtaaa attttccgtt tattaacagc ctgttgcatc tgctcatagt 5880 aaggcatcaa ctgcggtaaa atatcagcaa gtgcctgtct gtctttatcc aggatacggc 5940 tcaattgccc gatttttttc aagtcacgct cataggctat tctgtcgctg atctgctcgt 6000 atttttgctt tgaacacctt atgtactctt gcatatcgtt acttgcccat gcctgcgcct 6060 gaagacgtgt aaacatggaa atgtctgaag caacatggtc gctgatatgg tcatactcag 6120 catctttgac atagccgtat tttgataaat atctttcata gtcctgccgt ttctttttgt 6180 catcttcctg tttttgttta gtttctcttt ctatctgctg ttgttttcgt tgctgttcct 6240 gttgctcctc ttttatctct ctgtgataaa tggaaaggct agattgatca ttatcccaac 6300 gtgtgagcat gtcctcaaag ccgtaataat cagcactaaa ccaacctgtt ttcactttca 6360 ctggtggcgg cagtggctct ccgatctccc ttagcagtgc tgtagctgct cgtccctctt 6420 tgatcacttt atcaagctgc aagcggtcga tattgtcttg caaagccttg taaaatctat 6480 gctctgctcg cttctcatcc gtttttactt caatcaaata cacatctata agcgtttggc 6540 ggtgttgttg gtggtcgtat agtgcctgtt gtgcggtggc atagactgcg ggggcttggt 6600 ctacggcatc ctccagctgc ctcgcgcgtt tcggtgatga cggtgaaaac ctctgacaca 6660 tgcagctccc ggagacggtc acagcttgtc tgtaagcgga tgccgggagc agacaagccc 6720 gtcagggcgc gtcagcgggt gttggcgggt gtcggggcgc agccatgacc cagtcacgta 6780 gcgatagcgg agtgtatact ggcttaacta tgcggcatca gagcagattg tactgagagt 6840 gcaccatatg cggtgtgaaa taccgcacag atgcgtaagg agaaaatacc gcatcaggcg 6900 ctcttccgct tcctcgctca ctgactcgct gcgctcggtc gttcggctgc ggcgagcggt 6960 atcagctcac tcaaaggcgg taatacggtt atccacagaa tcaggggata acgcaggaaa 7020 gaacatgtga gcaaaaggcc agcaaaaggc caggaaccgt aaaaaggccg cgttgctggc 7080 gtttttccat aggctccgcc cccctgacga gcatcacaaa aatcgacgct caagtcagag 7140 gtggcgaaac ccgacaggac tataaagata ccaggcgttt ccccctggaa gctccctcgt 7200 gcgctctcct gttccgaccc tgccgcttac cggatacctg tccgcctttc tcccttcggg 7260 aagcgtggcg ctttctcata gctcacgctg taggtatctc agttcggtgt aggtcgttcg 7320 ctccaagctg ggctgtgtgc acgaaccccc cgttcagccc gaccgctgcg ccttatccgg 7380 taactatcgt cttgagtcca acccggtaag acacgactta tcgccactgg cagcagccac 7440 tggtaacagg attagcagag cgaggtatgt aggcggtgct acagagttct tgaagtggtg 7500 gcctaactac ggctacacta gaaggacagt atttggtatc tgcgctctgc tgaagccagt 7560 taccttcgga aaaagagttg gtagctcttg atccggcaaa caaaccaccg ctggtagcgg 7620 tggttttttt gtttgcaagc agcagattac gcgcagaaaa aaaggatctc aagaagatcc 7680 tttgatcttt tctacggggt ctgacgctca gtggaacgaa aactcacgtt aagggatttt 7740 ggtcatgaga ttatcaaaaa ggatcttcac ctagatcctt ttaaattaaa aatgaagttt 7800 taaatcaatc taaagtatat atgagtaaac ttggtctgac agttaccaat gcttaatcag 7860 tgaggcacct atctcagcga tctgtctatt tcgttcatcc atagttgcct gactccccgt 7920 cgtgtagata actacgatac gggagggctt accatctggc cccagtgctg caatgatacc 7980 gcgagaccca cgctcaccgg ctccagattt atcagcaata aaccagccag ccggaagggc 8040 cgagcgcaga agtggtcctg caactttatc cgcctccatc cagtctatta attgttgccg 8100 ggaagctaga gtaagtagtt cgccagttaa tagtttgcgc aacgttgttg ccattgctgc 8160 aggcaagtga agaaatggtg cagcgggcaa cagataatgc aaagcgtaat aatctggtgc 8220 aagcaagctt cttttcacaa gatttaacaa aagatttttc gcatcattct tgggcaaatc 8280 aaggatttga tgcattattg attgatcctc ctcgtgctgg tgcatatgaa attatgcagt 8340 atgtgccgaa ctttggagca aaaagaatcg tttatgtatc atgtaatcca gcaacattag 8400 caagggatgc aggtgttttg gttcaacatg gttaccagtt aaaaaaagca gcggttatgg 8460 acatgtttac gcacacagaa catgttgaat cgattgcttt atttgagaaa attcaagaga 8520 taaacgatta aaaacatgag ttacatatcc aggagaatgg tatgagccat attcaacggg 8580 aaacgtcttg ctcgaggccg cgattaaatt ccaacatgga tgctgattta tatgggtata 8640 aatgggctcg cgataatgtc gggcaatcag gtgcgacaat ctatcgattg tatgggaagc 8700 ccgatgcgcc agagttgttt ctgaaacatg gcaaaggtag cgttgccaat gatgttacag 8760 atgagatggt cagactaaac tggctgacgg aatttatgcc tcttccgacc atcaagcatt 8820 ttatccgtac tcctgatgat gcatggttac tcaccactgc gatccccggg aaaacagcat 8880 tccaggtatt agaagaatat cctgattcag gtgaaaatat tgttgatgcg ctggcagtgt 8940 tcctgcgccg gttgcattcg attcctgttt gtaattgtcc ttttaacagc gatcgcgtat 9000 ttcgtctcgc tcaggcgcaa tcacgaatga ataacggttt ggttgatgcg agtgattttg 9060 atgacgagcg taatggctgg cctgttgaac aagtctggaa agaaatgcat aagcttttgc 9120 cattctcacc ggattcagtc gtcactcatg gtgatttctc acttgataac cttatttttg 9180 acgaggggaa attaataggt tgtattgatg ttggacgagt cggaatcgca gaccgatacc 9240 aggatcttgc catcctatgg aactgcctcg gtgagttttc tccttcatta cagaaacggc 9300 tttttcaaaa atatggtatt gataatcctg atatgaataa attgcagttt catttgatgc 9360 tcgatgagtt tttctaatca gaattggtta attggttgta acactggcag agcattacgc 9420 tgacttgacg ggacggcggc tttgttgaat aaatcgaact tttgctgagt tgaaggatca 9480 gatcacgcat cttcccgaca acgcagaccg ttccgtggca aagcaaaagt tcaaaatcac 9540 caactggtcc acctacaaca aagctctcat caaccgtggc tccctcactt tctggctgga 9600 tgatggggcg attcaggcct ggtatgagtc agcaacacct tcttcacgag gcagacctgc 9660 aggcatcgtg gtgtcacgct cgtcgtttgg tatggcttca ttcagctccg gttcccaacg 9720 atcaaggcga gttacatgat cccccatgtt gtgcaaaaaa gcggttagct ccttcggtcc 9780 tccgatcgtt gtcagaagta agttggccgc agtgttatca ctcatggtta tggcagcact 9840 gcataattct cttactgtca tgccatccgt aagatgcttt tctgtgactg gtgagtactc 9900 aaccaagtca ttctgagaat agtgtatgcg gcgaccgagt tgctcttgcc cggcgtcaac 9960 acgggataat accgcgccac atagcagaac tttaaaagtg ctcatcattg gaaaacgttc 10020 ttcggggcga aaactctcaa ggatcttacc gctgttgaga tccagttcga tgtaacccac 10080 tcgtgcaccc aactgatctt cagcatcttt tactttcacc agcgtttctg ggtgagcaaa 10140 aacaggaagg caaaatgccg caaaaaaggg aataagggcg acacggaaat gttgaatact 10200 catactcttc ctttttcaat attattgaag catttatcag ggttattgtc tcatgagcgg 10260 atacatattt gaatgtattt agaaaaataa acaaataggg gttccgcgca catttccccg 10320 aaaagtgcca cctgacgtct aagaaaccat tattatcatg acattaacct ataaaaatag 10380 gcgtatcacg aggccctttc gtcttcaaga a 10411 <210> 4 <211> 934 <212> DNA <213> Artificial Sequence <220> <223> GlmS upstream <400> 4 tggtttgagc aattgacttg gtgtgccttg ccaagttgag attgcgagtg aattccgtta 60 tcgctcacca gtgattgtgg aaaatacact ttacatctgt atttcacaat caggcgaaac 120 agcggatacc ttagctgcac tacgtgaaac tcaaaaacgt gctaaagcaa ataatatcga 180 tattcagact ttaacgatct gtaacgtcgc aacttcttca atggtgcgtg aaactgatca 240 ccacttattg acgcttgcag gcccagagat tggggttgca tcaacaaaag cgttcacgac 300 tcagcttgct gcattaatgt tgttaatctt gaaaattggt caagtgaaac agcgtattag 360 caatgtgatg attgaagagc ttgctcgtga attgtggcat agcccgaaag tgattcttga 420 tacacttaag aatgatccag aaattttacg tttatcagaa ttgttcgttg aaaaacaaca 480 ctgtttattc ttaggccgtg gcacacacta tccaatcgct ttggaaggtg cattaaagct 540 taaagaaatt tcatatattc acgcagaagg ttatgcagct ggtgagttga aacacggccc 600 attggcactt gttgatactg aaatgccaat cgtgattctt gcaccaaatg acgaaatgct 660 tgataagctt aagtcaaata tggaagaagt tcaggctcgt ggcggtgaat tattcgtttt 720 cgctgatgaa aatagtggtg tagttgaaaa agaccgtcaa catgtcgttc atattccagc 780 agtaaacgaa tggcttgcac caatcattta tagcgtacca gttcagttat tgtcttatca 840 cgttgctgta ttacgtggta cagacgttga ccagccacgt aacttggcga agtcagtaac 900 tgtagagtaa ttcaaaaaag atcattatta aggc 934 <210> 5 <211> 951 <212> DNA <213> Artificial Sequence <220> <223> GlmS downstream <400> 5 atcacctgct ttaataattg attgattaag cccgatatgc attaattgcc tattgggctt 60 ttttattgcc ttcatatcgc tacacagaag ctttcctacg aaagaaaata gagaactctg 120 cttaggtccc cgtgtcacaa cggacttttt acttttgcgc tgatttaaag tttgagagat 180 cattgcgaca cagagataaa gaagctaagc gaacttagtc cattttattt ttgtcgcagc 240 gttgaatgct gctgaacaag ttaggggcaa agtcctgtgg gagaacagga ctttgcaaac 300 tggtgtgttt taaacgttgt acggtttgag gtgaatacac ctgtgcaagc tgttggcaaa 360 cacaattaca actggcttac atgtgttcac ctgacaaaca aattctttta aattcctgct 420 gagcattggc atcatcattt gtaatactgt aagcaccgac cacaaggttt aaaatcaata 480 taaatttatg aagtttcata ttattctcat gattatttat aaatttaaat aaaataaaaa 540 tatggttcaa ttaaatatta aaataatttt ttaaataata attaatcctc ccacaaacat 600 aggaaaataa aataattaaa attttaaaat agaaataatt tataaattta aaaaaacagg 660 tcgcaaaaaa cccaaatttt aaataaataa aatagttaac taaaagagaa aatgagtttt 720 aataatggca tggccaactc cttaaaaatg gagttctacc accagattac cgcgaactaa 780 tttagggtgg tagaacgaaa gagggttagc agactgacct agcgaccagc acgcgcgaac 840 gcgtccccct tccgccctac catagagaaa aagggggcac aaaggttcca cacgggtaat 900 actgaggaag tataacccga cacgctaggg tacggtctgc taaaaccgac t 951 <210> 6 <211> 10483 <212> DNA <213> Artificial Sequence <220> <223> pDM4_A1S0579p-npt I <400> 6 gatccttttt gtccggtgtt gggttgaagg tgaagccggt cggggccgca gcgggggccg 60 gcttttcagc cttgcccccc tgcttcggcc gccgtggctc cggcgtcttg ggtgccggcg 120 cgggttccgc agccttggcc tgcggtgcgg gcacatcggc gggcttggcc ttgatgtgcc 180 gcctggcgtg cgagcggaac gtctcgtagg agaacttgac cttccccgtt tcccgcatgt 240 gctcccaaat ggtgacgagc gcatagccgg acgctaacgc cgcctcgaca tccgccctca 300 ccgccaggaa cgcaaccgca gcctcatcac gccggcgctt cttggccgcg cgggattcaa 360 cccactcggc cagctcgtcg gtgtagctct ttggcatcgt ctctcgcctg tcccctcagt 420 tcagtaattt cctgcatttg cctgtttcca gtcggtagat attccacaaa acagcaggga 480 agcagcgctt ttccgctgca taaccctgct tcggggtcat tatagcgatt ttttcggtat 540 atccatcctt tttcgcacga tatacaggat tttgccaaag ggttcgtgta gactttcctt 600 ggtgtatcca acggcgtcag ccgggcagga taggtgaagt aggcccaccc gcgagcgggt 660 gttccttctt cactgtccct tattcgcacc tggcggtgct caacgggaat cctgctctgc 720 gaggctggcc ggctaccgcc ggcgtaacag atgagggcaa gcggatggct gatgaaacca 780 agccaaccag gaagggcagc ccacctatca aggtgtactg ccttccagac gaacgaagag 840 cgattgagga aaaggcggcg gcggccggca tgagcctgtc ggcctacctg ctggccgtcg 900 gccagggcta caaaatcacg ggcgtcgtgg actatgagca cgtccgcgag ctggcccgca 960 tcaatggcga cctgggccgc ctgggcggcc tgctgaaact ctggctcacc gacgacccgc 1020 gcacggcgcg gttcggtgat gccacgatcc tcgccctgct ggcgaagatc gaagagaagc 1080 aggacgagct tggcaaggtc atgatgggcg tggtccgccc gagggcagag ccatgacttt 1140 tttagccgct aaaacggccg gggggtgcgc gtgattgcca agcacgtccc catgcgctcc 1200 atcaagaaga gcgacttcgc ggagctggtg aagtacatca ccgacgagca aggcaagacc 1260 gagcgcctgg gtcacgtgcg cgtcacgaac tgcgaggcaa acaccctgcc cgctgtcatg 1320 gccgaggtga tggcgaccca gcacggcaac acccgttccg aggccgacaa gacctatcac 1380 ctgctggtta gcttccgcgc gggagagaag cccgacgcgg agacgttgcg cgcgattgag 1440 gaccgcatct gcgctgggct tggcttcgcc gagcatcagc gcgtcagtgc cgtgcatcac 1500 gacaccgaca acctgcacat ccatatcgcc atcaacaaga ttcacccgac ccgaaacacc 1560 atccatgagc cgtatcgggc ctaccgcgcc ctcgctgacc tctgcgcgac gctcgaacgg 1620 gactacgggc ttgagcgtga caatcacgaa acgcggcagc gcgtttccga gaaccgcgcg 1680 aacgacatgg agcggcacgc gggcgtggaa agcctggtcg gctggatccg gccacgatgc 1740 gtccggcgta gaggatctga agatcagcag ttcaacctgt tgatagtacg tactaagctc 1800 tcatgtttca cgtactaagc tctcatgttt aacgtactaa gctctcatgt ttaacgaact 1860 aaaccctcat ggctaacgta ctaagctctc atggctaacg tactaagctc tcatgtttca 1920 cgtactaagc tctcatgttt gaacaataaa attaatataa atcagcaact taaatagcct 1980 ctaaggtttt aagttttata agaaaaaaaa gaatatataa ggcttttaaa gcttttaagg 2040 tttaacggtt gtggacaaca agccagggat gtaacgcact gagaagccct tagagcctct 2100 caaagcaatt ttgagtgaca caggaacact taacggctga catgggaatt ccacatgtgg 2160 aattccacat gtggaattgt gagcggataa caatttgtgg aatcccggga gagctcaggt 2220 tacccgcatg caagatctat ctagaagggc ccagtcggtt ttagcagacc gtaccctagc 2280 gtgtcgggtt atacttcctc agtattaccc gtgtggaacc tttgtgcccc ctttttctct 2340 atggtagggc ggaaggggga cgcgttcgcg cgtgctggtc gctaggtcag tctgctaacc 2400 ctctttcgtt ctaccaccct aaattagttc gcggtaatct ggtggtagaa ctccattttt 2460 aaggagttgg ccatgccatt attaaaactc attttctctt ttagttaact attttattta 2520 tttaaaattt gggttttttg cgacctgttt ttttaaattt ataaattatt tctattttaa 2580 aattttaatt attttatttt cctatgtttg tgggaggatt aattattatt taaaaaatta 2640 ttttaatatt taattgaacc atatttttat tttatttaaa tttataaata atcatgagaa 2700 taatatgaaa cttcataaat ttatattgat tttaaacctt gtggtcggtg cttacagtat 2760 tacaaatgat gatgccaatg ctcagcagga atttaaaaga atttgtttgt caggtgaaca 2820 catgtaagcc agttgtaatt gtgtttgcca acagcttgca caggtgtatt cacctcaaac 2880 cgtacaacgt ttaaaacaca ccagtttgca aagtcctgtt ctcccacagg actttgcccc 2940 taacttgttc agcagcattc aacgctgcga caaaaataaa atggactaag ttcgcttagc 3000 ttctttatct ctgtgtcgca atgatctctc aaactttaaa tcagcgcaaa agtaaaaagt 3060 ccgttgtgac acggggacct aagcagagtt ctctattttc tttcgtagga aagcttctgt 3120 gtagcgatat gaaggcaata aaaaagccca ataggcaatt aatgcatatc gggcttaatc 3180 aatcaattat taaagcaggt gatgtctgcc tcgtgaagaa ggtgttgctg actcatacca 3240 ggcctgaatc gccccatcat ccagccagaa agtgagggag ccacggttga tgagagcttt 3300 gttgtaggtg gaccagttgg tgattttgaa cttttgcttt gccacggaac ggtctgcgtt 3360 gtcgggaaga tgcgtgatct gatccttcaa ctcagcaaaa gttcgattta ttcaacaaag 3420 ccgccgtccc gtcaagtcag cgtaatgctc tgccagtgtt acaaccaatt aaccaattct 3480 gattagaaaa actcatcgag catcaaatga aactgcaatt tattcatatc aggattatca 3540 ataccatatt tttgaaaaag ccgtttctgt aatgaaggag aaaactcacc gaggcagttc 3600 cataggatgg caagatcctg gtatcggtct gcgattccga ctcgtccaac atcaatacaa 3660 cctattaatt tcccctcgtc aaaaataagg ttatcaagtg agaaatcacc atgagtgacg 3720 actgaatccg gtgagaatgg caaaagctta tgcatttctt tccagacttg ttcaacaggc 3780 cagccattac gctcgtcatc aaaatcactc gcatcaacca aaccgttatt cattcgtgat 3840 tgcgcctgag cgagacgaaa tacgcgatcg ctgttaaaag gacaattaca aacaggaatc 3900 gaatgcaacc ggcgcaggaa cactgccagc gcatcaacaa tattttcacc tgaatcagga 3960 tattcttcta atacctggaa tgctgttttc ccggggatcg cagtggtgag taaccatgca 4020 tcatcaggag tacggataaa atgcttgatg gtcggaagag gcataaattc cgtcagccag 4080 tttagtctga ccatctcatc tgtaacatca ttggcaacgc tacctttgcc atgtttcaga 4140 aacaactctg gcgcatcggg cttcccatac aatcgataga ttgtcgcacc tgattgcccg 4200 acattatcgc gagcccattt atacccatat aaatcagcat ccatgttgga atttaatcgc 4260 ggcctcgagc aagacgtttc ccgttgaata tggctcatac cattctcctg gatatgtaac 4320 tcatgttttt aatcgtttat ctcttgaatt ttctcaaata aagcaatcga ttcaacatgt 4380 tctgtgtgcg taaacatgtc cataaccgct gcttttttta actggtaacc atgttgaacc 4440 aaaacacctg catcccttgc taatgttgct ggattacatg atacataaac gattcttttt 4500 gctccaaagt tcggcacata ctgcataatt tcatatgcac cagcacgagg aggatcaatc 4560 aataatgcat caaatccttg atttgcccaa gaatgatgcg aaaaatcttt tgttaaatct 4620 tgtgaaaaga agcttgcttg caccagatta ttacgctttg cattatctgt tgcccgctgc 4680 accatttctt cacttgctgc cttaataatg atcttttttg aattactcta cagttactga 4740 cttcgccaag ttacgtggct ggtcaacgtc tgtaccacgt aatacagcaa cgtgataaga 4800 caataactga actggtacgc tataaatgat tggtgcaagc cattcgttta ctgctggaat 4860 atgaacgaca tgttgacggt ctttttcaac tacaccacta ttttcatcag cgaaaacgaa 4920 taattcaccg ccacgagcct gaacttcttc catatttgac ttaagcttat caagcatttc 4980 gtcatttggt gcaagaatca cgattggcat ttcagtatca acaagtgcca atgggccgtg 5040 tttcaactca ccagctgcat aaccttctgc gtgaatatat gaaatttctt taagctttaa 5100 tgcaccttcc aaagcgattg gatagtgtgt gccacggcct aagaataaac agtgttgttt 5160 ttcaacgaac aattctgata aacgtaaaat ttctggatca ttcttaagtg tatcaagaat 5220 cactttcggg ctatgccaca attcacgagc aagctcttca atcatcacat tgctaatacg 5280 ctgtttcact tgaccaattt tcaagattaa caacattaat gcagcaagct gagtcgtgaa 5340 cgcttttgtt gatgcaaccc caatctctgg gcctgcaagc gtcaataagt ggtgatcagt 5400 ttcacgcacc attgaagaag ttgcgacgtt acagatcgtt aaagtctgaa tatcgatatt 5460 atttgcttta gcacgttttt gagtttcacg tagtgcagct aaggtatccg ctgtttcgcc 5520 tgattgtgaa atacagatgt aaagtgtatt ttccacaatc actggtgagc gataacggaa 5580 ttcactcgca atctcaactt ggcaaggcac accaagtcaa ttgctcaaac caactagtga 5640 cgcgtactcg agggtcgacg gtatcgataa gcttgatata cactccgcta gcgctgatgt 5700 ccggcggtgc ttttgccgtt acgcaccacc ccgtcagtag ctgaacagga gggacagctg 5760 atagaaacag aagccactgg agcacctcaa aaacaccatc atacactaaa tcagtaagtt 5820 ggcagcatca cccgacgcac tttgcgccga ataaatacct gtgacggaag atcacttcgc 5880 agaataaata aatcctggtg tccctgttga taccgggaag ccctgggcca acttttggcg 5940 aaaatgagac gttgatcggc acgtaagagg ttccaacttt caccataatg aaataagatc 6000 actaccgggc gtattttttg agttatcgag attttcagga gctaargaag ctaaaatgga 6060 gaaaaaaatc actggatata ccaccgttga tatatcccaa tggcatcgta aagaacattt 6120 tgaggcattt cagtcagttg ctcaatgtac ctataaccag accgttcagc tggatattac 6180 ggccttttta aagaccgtaa agaaaaataa gcacaagttt tatccggcct ttattcacat 6240 tcttgcccgc ctgatgaatg ctcatccgga attccgtatg gcaatgaaag acggtgagct 6300 ggtgatatgg gatagtgttc acccttgtta caccgttttc catgagcaaa ctgaaacgtt 6360 ttcatcgctc tggagtgaat accacgacga tttccggcag tttctacaca tatattcgca 6420 agatgtggcg tgttacggtg aaaacctggc ctatttccct aaagggttta ttgagaatat 6480 gtttttcgtc tcagccaatc cctgggtgag tttcaccagt tttgatttaa acgtggccaa 6540 tatggacaac ttcttcgccc ccgttttcac catgggcaaa tattatacgc aaggcgacaa 6600 ggtgctgatg ccgctggcga ttcaggttca tcatgccgtt tgtgatggct tccatgtcgg 6660 cagaatgctt aatgaattac aacagtactg cgatgagtgg cagggcgggg cgtaattttt 6720 ttaaggcagt tattggtgcc cttaaacgcc tggttgctac gcctgaataa gtgataataa 6780 gcggatgaat ggcagaaatt cgaaagcaaa ttcgacccgg tcgtcggttc agggcagggt 6840 cgttaaatag ccgcttatgt ctattgctgg tttaccggtt tattgactac cggaagcagt 6900 gtgaccgtgt gcttctcaaa tgcctgaggc cagwttgctc agctctcccg tggaggtaat 6960 aattgacgat atgatcattt attctgcctc ccagagcctg ataaaaacgg ttagcgcttc 7020 gttaatacag atgtaggtgt tccacagggt agccagcagc atcctgcgat gcagatcatc 7080 gaattcctgc agccaagcta gacctaggcc ttaagatcct ttttaaccca tcacatatac 7140 ctgccgttca ctattattta gtgaaatgag atattatgat attttctgaa ttgtgattaa 7200 aaaggcaact ttatgcccat gcaacagaaa ctataaaaaa tacagagaat gaaaagaaac 7260 agatagattt tttagttctt taggcccgta gtctgcaaat ccttttatga ttttctatca 7320 aacaaaagag gaaaatagac cagttgcaat ccaaacgaga gtctaataga atgaggtcga 7380 aaagtaaatc gcgcgggttt gttactgata aagcaggcaa gacctaaaat gtgtaaaggg 7440 caaagtgtat actttggcgt caccccttac atattttagg tcttttttta ttgtgcgtaa 7500 ctaacttgcc atcttcaaac aggagggctg gaagaagcag accgctaaca cagtacataa 7560 aaaaggagac atgaacgatg aacatcaaaa agtttgcaaa acaagcaaca gtattaacct 7620 ttactaccgc actgctggca ggaggcgcaa ctcaagcgtt tgcgaaagaa acgaaccaaa 7680 agccatataa ggaaacatac ggcatttccc atattacacg ccatgatatg ctgcaaatcc 7740 ctgaacagca aaaaaatgaa aaatatcaag ttcctgaatt cgattcgtcc acaattaaaa 7800 atatctcttc tgcaaaaggc ctggacgttt gggacagctg gccattacaa aacgctgacg 7860 gcactgtcgc aaactatcac ggctaccaca tcgtctttgc attagccgga gatcctaaaa 7920 atgcggatga cacatcgatt tacatgttct atcaaaaagt cggcgaaact tctattgaca 7980 gctggaaaaa cgctggccgc gtctttaaag acagcgacaa attcgatgca aatgattcta 8040 tcctaaaaga ccaaacacaa gaatggtcag gttcagccac atttacatct gacggaaaaa 8100 tccgtttatt ctacactgat ttctccggta aacattacgg caaacaaaca ctgacaactg 8160 cacaagttaa cgtatcagca tcagacagct ctttgaacat caacggtgta gaggattata 8220 aatcaatctt tgacggtgac ggaaaaacgt atcaaaatgt acagcagttc atcgatgaag 8280 gcaactacag ctcaggcgac aaccatacgc tgagagatcc tcactacgta gaagataaag 8340 gccacaaata cttagtattt gaagcaaaca ctggaactga agatggctac caaggcgaag 8400 aatctttatt taacaaagca tactatggca aaagcacatc attcttccgt caagaaagtc 8460 aaaaacttct gcaaagcgat aaaaaacgca cggctgagtt agcaaacggc gctctcggta 8520 tgattgagct aaacgatgat tacacactga aaaaagtgat gaaaccgctg attgcatcta 8580 acacagtaac agatgaaatt gaacgcgcga acgtctttaa aatgaacggc aaatggtacc 8640 tgttcactga ctcccgcgga tcaaaaatga cgattgacgg cattacgtct aacgatattt 8700 acatgcttgg ttatgtttct aattctttaa ctggcccata caagccgctg aacaaaactg 8760 gccttgtgtt aaaaatggat cttgatccta acgatgtaac ctttacttac tcacacttcg 8820 ctgtacctca agcgaaagga aacaatgtcg tgattacaag ctatatgaca aacagaggat 8880 tctacgcaga caaacaatca acgtttgcgc caagcttcct gctgaacatc aaaggcaaga 8940 aaacatctgt tgtcaaagac agcatccttg aacaaggaca attaacagtt aacaaataaa 9000 aacgcaaaag aaaatgccga tatcctatng gcattttctt ttatttctta tcaacataaa 9060 ggtgaatccc atatgaacta tataaaagca ggcaaatggc taaccgtatt cctaaccttt 9120 tggtaatgac tccaacttat tgatagtgtt ttatgttcag ataatgcccg atgactttgt 9180 catgcagctc caccgatttt gagaacgaca gcgacttccg tcccagccgt gccaggtgct 9240 gcctcagatt caggttatgc cgctcaattc gctgcgtata tcgcttgctg attacgtgca 9300 gctttccctt caggcgggat tcatacagcg gccagccatc cgtcatccat atcaccacgt 9360 caaagggtga cagcaggctc ataagacgcc ccagcgtcgc catagtgcgt tcaccgaata 9420 cgtgcgcaac aaccgtcttc cggagactgt catacgcgta aaacagccag cgctggcgcg 9480 atttagcccc gacatagccc cactgttcgt ccatttccgc gcagacgatg acgtcactgc 9540 ccggctgtat gcgcgaggtt accgactgcg gcctgagttt tttaagtgac gtaaaatcgt 9600 gttgaggcca acgcccataa tgcgggctgt tgcccggcat ccaacgccat tcatggccat 9660 atcaatgatt ttctggtgcg taccgggttg agaagcggtg taagtgaact gcagcaatgg 9720 caacaacgtt gcgcaaacta ttaactggcg aactacttac tctagcttcc cggcaacaat 9780 taatagactg gatggaggcg gataaagttg caggaccact tctgcgctcg gcccttccgg 9840 ctggctggtt tattgctgat aaatctggag ccggtgagcg tgggtctcgc ggtatcattg 9900 cagcactggg gccagatggt aagccctccc gtatcgtagt tatctacacg acggggagtc 9960 aggcaactat ggatgaacga aatagacaga tcgctgagat aggtgcctca ctgattaagc 10020 attggtaact gtcagaccaa gtttactcat atatacttta gattgattta tggtgcactc 10080 tcagtacaat ctgctctgat gccgcatagt taagccagta tacactccgc tatcgctacg 10140 tgactgggtc atggctgcgc cccgacaccc gccaacaccc gctgacgcgc cctgacgggc 10200 ttgtctgctc ccggcatccg cttacagaca agctgtgacc gtctccggga gctgcatgtg 10260 tcagaggttt tcaccgtcat caccgaaacg cgcgaggcag caaggagatg gcgcccaaca 10320 gtcccccggc cacggggcct gccaccatac ccacgccgaa acaagcgctc atgagcccga 10380 agtggcgagc ccgatcttcc ccatcggtga tgtcggcgat ataggcgcca gcaaccgcac 10440 ctgtggcgcc ggtgatgccg gccacgatgc gtccggcgta gag 10483 <210> 7 <211> 29 <212> DNA <213> Artificial Sequence <220> <223> Primer - GlmS_Up_F_spe I <400> 7 ggactagttg gtttgagcaa ttgacttgg 29 <210> 8 <211> 45 <212> DNA <213> Artificial Sequence <220> <223> Primer - GlmS_Up_R <400> 8 cttcacttgc tgccttaata atgatctttt ttgaattact ctaca 45 <210> 9 <211> 50 <212> DNA <213> Artificial Sequence <220> <223> Primer - A1S_0579p_F <400> 9 gtaattcaaa aaagatcatt attaaggcag caagtgaaga aatggtgcag 50 <210> 10 <211> 32 <212> DNA <213> Artificial Sequence <220> <223> Primer - A1S_0579p_R <400> 10 tggctcatac cattctcctg gatatgtaac tc 32 <210> 11 <211> 34 <212> DNA <213> Artificial Sequence <220> <223> Primer - Npt I_F <400> 11 caggagaatg gtatgagcca tattcaacgg gaaa 34 <210> 12 <211> 28 <212> DNA <213> Artificial Sequence <220> <223> Primer - Npt I_R <400> 12 gcaggtgatg tctgcctcgt gaagaagg 28 <210> 13 <211> 39 <212> DNA <213> Artificial Sequence <220> <223> Primer - GlmS_Down_F <400> 13 aggcagacat cacctgcttt aataattgat tgattaagc 39 <210> 14 <211> 28 <212> DNA <213> Artificial Sequence <220> <223> Primer - GlmS_Down_R_Apa I <400> 14 gttgggccca gtcggtttta gcagaccg 28 <210> 15 <211> 29 <212> DNA <213> Artificial Sequence <220> <223> Primer - A1S_0579p_F_pst I <400> 15 aactgcaggc aagtgaagaa atggtgcag 29 <210> 16 <211> 27 <212> DNA <213> Artificial Sequence <220> <223> Primer - Npt I_R_pst I <400> 16 aactgcaggt ctgcctcgtg aagaagg 27 <110> Kyungpook National University Industry-Academic Cooperation Foundation <120> Recombinant plasmids and mutant strains for screening inhibitors of ppGpp biosynthesis-related gene expression <130> PN200045 <160> 16 <170> KoPatentIn 3.0 <210> 1 <211> 399 <212> DNA <213> Artificial Sequence <220> <223> A1S_0579 Promoter <400> 1 gcaagtgaag aaatggtgca gcgggcaaca gataatgcaa agcgtaataa tctggtgcaa 60 gcaagcttct tttcacaaga tttaacaaaa gatttttcgc atcattcttg ggcaaatcaa 120 ggatttgatg cattattgat tgatcctcct cgtgctggtg catatgaaat tatgcagtat 180 gtgccgaact ttggagcaaa aagaatcgtt tatgtatcat gtaatccagc aacattagca 240 agggatgcag gtgttttggt tcaacatggt taccagttaa aaaaagcagc ggttatggac 300 atgtttacgc acacagaaca tgttgaatcg attgctttat ttgagaaaat tcaagagata 360 aacgattaaa aacatgagtt acatatccag gagaatggt 399 <210> 2 <211> 1095 <212> DNA <213> Artificial Sequence <220> <223> npt I <400> 2 atgagccata ttcaacggga aacgtcttgc tcgaggccgc gattaaattc caacatggat 60 gctgatttat atgggtataa atgggctcgc gataatgtcg ggcaatcag g tgcgacaatc 120 tatcgattgt atgggaagcc cgatgcgcca gagttgtttc tgaaacatgg caaaggtagc 180 gttgccaatg atgttacaga tgagatggtc agactaaact ggctgacgga atttatgcct 240 cttccgacca tcaagcattt tatccgtact cctgatgatg catggttact caccactgcg 300 atccccggga aaacagcatt ccaggtatta gaagaatatc ctgattcagg tgaaaatatt 360 gttgatgcgc tggcagtgtt cctgcgccgg ttgcattcga ttcctgtttg taattgtcct 420 tttaacagcg atcgcgtatt tcgtctcgct caggcgcaat cacgaatgaa taacggtttg 480 gttgatgcga gtgattttga tgacgagcgt aatggctggc ctgttgaaca agtctggaaa 540 gaaatgcata agcttttgcc attctcaccg gattcagtcg tcactcatgg tgatttctca 600 cttgataacc ttatttttga cgaggggaaa ttaataggtt gtattgatgt tggacgagtc 660 ggaatcgcag accgatacca ggatcttgcc atcctatgga actgcctcgg tgagttttct 720 ccttcattac agaaacggct ttttcaaaaa tatggtattg ataatcctga tatgaataaa 780 ttgcagtttc atttgatgct cgatgagttt ttctaatcag aattggttaa ttggttgtaa 840 cactggcaga gcattacgct gacttgacgg gacggcggct ttgttgaata aatcgaactt 900 ttgctgagtt gaaggatcag atcacgcatc ttcccgacaa cgcagaccgt tccgtggcaa 960 agc aaaagtt caaaatcacc aactggtcca cctacaacaa agctctcatc aaccgtggct 1020 ccctcacttt ctggctggat gatggggcga ttcaggcctg gtatgagtca gcaacacctt 1080 cttcacgagg cagac 1095 <210> 3 <211> 10411 <212> DNA <213> Artificial Sequence <220> <223> pWH1266_A1S0579p-npt I <400> 3 ttctcatgtt tgacagctta tcatcgataa gctttaatgc ggtagtttat cacagttaaa 60 ttgctaacgc agtcaggcac cgtgtatgaa atctaacaat gcgctcatcg tcatcctcgg 120 caccgtcacc ctggatgctg taggcatagg cttggttatg ccggtactgc cgggcctctt 180 gcgggatatc gtccattccg acagcatcgc cagtcactat ggcgtgctgc tagcgctata 240 tgcgttgatg caatttctat gcgcacccgt tctcggagca ctgtccgacc gctttggccg 300 ccgcccagtc ctgctcgctt cgctacttgg agccactatc gactacgcga tcatggcgac 360 cacacccgtc ctgtggatcc tctacgccgg acgcatcgtg gccggcatca ccggcgccac 420 aggtgcggtt gctggcgcct atatcgccga catcaccgat ggggaagatc gggctcgcca 480 cttcgggctc atgagcgctt gtttcggcgt gggtatggtg gcaggccccg tggccggggg 540 actgttgggc gccatctcct tgcatgcacc attgccttgtgcgctgctg cctg ctgcatgcacc attagccttgtgcg gcctgc ggct at aagggagagc gtcgaccgat 660 gcccttgaga gccttcaacc cagtcagctc cttccggtgg gcgcggggca tgactatcgt 720 cgccgcactt atgactgtct tctttatcat gcaactcgta ggacaggtgc cggcagcgct 780 ctgggtcatt ttcggcgagg accgctttcg ctggagcgcg acgatgatcg gcctgtcgct 840 tgcggtattc ggaatcttgc acgccctcgc tcaagccttc gtcactggtc ccgccaccaa 900 acgtttcggc gagaagcagg ccattatcgc cggcatggcg gccgacgcgc tgggctacgt 960 cttgctggcg ttcgcgacgc gaggctggat ggccttcccc attatgattc ttctcgcttc 1020 cggcggcatc gggatgcccg cgttgcaggc catgctgtcc aggcaggtag atgacgacca 1080 tcagggacag cttcaaggat cgctcgcggc tcttaccagc ctaacttcga tcattggacc 1140 gctgatcgtc acggcgattt atgccgcctc ggcgagcaca tggaacgggt tggcatggat 1200 tgtaggcgcc gccctatacc ttgtctgcct ccccgcgttg cgtcgcggtg catggagccg 1260 ggccacctcg acctgaatgg aagccggcgg cacctcgcta acggattcac cactccaaga 1320 attggagcca atcaattctt gcggagaact gtgaatgcgc aaaccaaccc ttggcagaac 1380 atatccatcg cgtccgccat ctccagcagc cgcacgcggc gcatctcggg cagcgttggg 1440 tcctggccac gggtgcgcat gatcgtgctc ctgtcgttga ggacccggc t aggctggcgg 1500 ggttgcctta ctggttagca gaatgaatca ccgatacgcg agcgaacgtg aagcgactgc 1560 tgctgcaaaa cgtctgcgac ctgagcaaca acatgaatgg tcttcggttt ccgtgtttcg 1620 taaagtctgg aaacgcggaa gtcagcgccc tgcaccatta tgttccggat ctgcatcgca 1680 ggatgctgct ggctaccctg tggaacacct acatctgtat taacgaagcg ctggcattga 1740 ccctgagtga tttttctctg gtcccgccgc atccataccg ccagttgttt accctcacaa 1800 cgttccagta accgggcatg ttcatcatca gtaacccgta tcgtgagcat cctctctcgt 1860 ttcatcggta tcattacccc catgaacaga aatccccctt acacggaggc atcagtgacc 1920 aaacaggaaa aaaccgccct taacatggcc cgctttatca gaagccagac attaacgctt 1980 ctggagaaac tcaacgagct ggacgcggat gaacaggcag acatctgtga atcgcttcac 2040 gaccacgctg atgagcttta ccgcagctgc tgctgttgct gctgttcaag tgtcaattgc 2100 tctactctgt tgctcgtctc aatgatagac atatcaagcc tttcagcttt tttattgcgc 2160 tttttgattt catcattacg cttgacgatc tccagttcct cccccctgcg cttggcgtgg 2220 gtggcttcaa gtccctcctt gaatgtcggc tcgatgtcta gtccacgatc cttatgactg 2280 cggtgatcaa ctctcacctc aagccctgct cgctctaggt ggacgttcgt caga tccgcc 2340 actttttccc tgattttttt cagcgttgag ttctgatcta gctccctgac tttcttccct 2400 agcccttgcg gtgtaaggct tcttgttgtc attagtatgt gggcgtgatg gtttctttca 2460 tcacttcccc catgcacatg aggggcatgg atcgctacgt ccaccgccac tccataggct 2520 ttaactaagg actggcacaa ctcggtaaca agtgcctgac gctgtgtctt atccagttca 2580 tgcggcaatg ctatctctac ttcctttgct aatcttgcct cctgtttgat gtcaccgttc 2640 ttttttagtt cggattgctc tacccgattc catagggttt gacgatctaa catgtcagga 2700 cttgccccag ttggggcaaa aatttgggtg tattcaatgc ctgttttttt ggtgtagtcc 2760 tgctcttttc cgtacgtatc acagtacaat ttttcgcctg ctcggtatgc tgcacatgcc 2820 acgattgagc gaccatctga cctcgaaatg ttctgcattt cacaatggta aattgccatt 2880 ttcatcacct gtttattaac agccgcccca agttttgggc ggttggggtg tcggggtttc 2940 cctgaccgta cttgcaaaat ttggcgtagc aaaaattttg cgtaagtgcg cccttcggga 3000 actctgcgag gctaaaagca aaagcaagag caataaggct ttgactttgt tttttgattt 3060 tgctcgctgc gctcggatct tgatgtaagt cgagtttttg aagtagaaca cttttcacat 3120 tgatgatggt tcatacttcg gaaaataggt tgagacacag gcattaaaaa tggtcaaaaa 3180 aacagctatg gaattgggtc aaatgctcga tgaagaaaag gaaaaattgg aacgtcagga 3240 aaaggcaaga aaggatctag ctgacgctgt ggtgaaaggt cgagagcaaa aacaggcaag 3300 gtcagacgat gcaaaacgca agatcctgat cggggcttac ttactgaaga aacatgataa 3360 tgacatcaag aaacttgtgg aacaaaaccc cgattttatt gggtacatta gagaaaatga 3420 taagcactta ttttcatagg cattagtagt tataaaaaac cctcataaat cgagggtttc 3480 ttttttatct gcattacttt ttgaatcaat gtactttttt agcttgctat ttttcactgc 3540 atacagccgc ttatactctt tctcaatcaa tgcggtcaaa atggcttttt ggctctcccc 3600 tgctgcgccc accatgtccg caagcatatc cgacacaccc ttatctataa acacctccaa 3660 acgttgacta tcaaggcttt tgcgtttttc acgatatgct ttttgtcgtt cggcattggt 3720 ttttggcggc tcttttagca tgtcctgtgt tttctgatcg ttcgggtctt tcatgtcttt 3780 aactcccata tagtatatca tagttacagg ataacattgt ttttagttac aggataactt 3840 tttataaaat ttatttgtaa aaatttatgc tatcctgcaa ctatttttaa attacaggat 3900 aactatttaa cgttaccctg taactatagt tatcctgtaa cgctaaatta attaccctgt 3960 aacatatatt ttgttatcct gtaacaacta aatattgaaa taatactacc aaagttaccc 4020 tgtaacgaaa ataactaggt taaaaaatga tcggatttta acattttgcg ttgttccaaa 4080 agttatcaac agcctagaac gtcataggaa gcgattacag acactttata gctatcagca 4140 tgggaacata agggcaggat gaaatatggg tcttaaaacg caaatggtga ggttttagag 4200 gtattttttg aagatgatta aggcggtttg tttttaaaat ttttggcggc tctcaggctg 4260 cttacatttt aaccagttca gtgaaaagtt ctttttcagc aaatttctgt ttagcaccat 4320 agctaaaact tgcgtggaac atattaagaa ttgaccgaaa tgacacaatc tcaattatat 4380 tttttttgaa aagttttctt tatcaaatat tttaaatcat tgatttatat ataagtatac 4440 attcatttta ataattaatc tttatttaac aatgatttat ctatattcaa ttgtttaatt 4500 attcttacta atattatctc tatatcaata ttttttattt aaaaacatat gtttagtagt 4560 gcttttgatt aaagtaccag agggagggag cagagctgaa tgggaaatac tcaccctaga 4620 gcgattctta aaaatcaccc taaagtattc ccattcgatg taccgtcggt cggtcgcttt 4680 cgcatcaggg atgacatcac tgtatcaagc tgccactgtt atgattacga ttgatagcac 4740 cgcctgaaca cgctcataac cgccaattaa atgactactc attgcgtccg ctactctgtt 4800 cagttcccct agtaatagcg tttttccgat gtgtgctagc gtcactgtac ctcatcaccc 4860 acacat ggac agattgagtt acagacattg gctaaatttt tggggtctat gcttgacaaa 4920 gcgagttaaa accttagaat ttaagacagg tacattaagc ccctgtggtg aaatcattag 4980 cggtcgtcaa accttaatgc tttcgattgc cgatatgtca gtatcgaaga tctgtacccc 5040 ataaattacg gtaaagcccc aagcaattgc aaggggcttt tatctttttt aacaaaaaaa 5100 atttataaat caggatttta taacactaaa taatccaaag tacatgagta agtcatgacc 5160 actcctgcga tgtgtgtagc actctgagta tccgtattat atcagtgatg tcatatacaa 5220 ccacataatg cggatgtatc actaactccc tagtatcttt ctgtctgcct gtgcgcccca 5280 tcagtcgatt atcaacaact aaatctgtct tttcttcaat taaatcatca atttcaatag 5340 ctgctatagg gttgcgttct tcaagataat catagatatt tctacgatct tggcgagctg 5400 tttcagtcca ctcaatcttc attcttcgct gccagtttcg ccaatgttgc agcacgtcta 5460 gcggcaaact ctgcctttac gtcctcatgt ggaatcaact tgcctgcatt ggcttcattt 5520 aagccgatct gtacctgctg cttgaaccat ttgtcatagt ctgcggcttc ctgttgcttc 5580 ttaacaaagt cacgcatgaa gtcacggatt agctgcgccc ccgaccgatc aacagtctta 5640 gcaaggcttg aaaattcttg ctttaggtca tggtctaccc gaaaggtaaa agtcgcttct 5700 gtcatgtttt t cactccaat gtgttacatt tgaatgctat tgtaacacat taaaaagtta 5760 ggtcattgtc ttttttcggc ttaggctgtt cttggtcata acgtggttta aatgatggct 5820 gtcgctcatt ctcaagtaaa attttccgtt tattaacagc ctgttgcatc tgctcatagt 5880 aaggcatcaa ctgcggtaaa atatcagcaa gtgcctgtct gtctttatcc aggatacggc 5940 tcaattgccc gatttttttc aagtcacgct cataggctat tctgtcgctg atctgctcgt 6000 atttttgctt tgaacacctt atgtactctt gcatatcgtt acttgcccat gcctgcgcct 6060 gaagacgtgt aaacatggaa atgtctgaag caacatggtc gctgatatgg tcatactcag 6120 catctttgac atagccgtat tttgataaat atctttcata gtcctgccgt ttctttttgt 6180 catcttcctg tttttgttta gtttctcttt ctatctgctg ttgttttcgt tgctgttcct 6240 gttgctcctc ttttatctct ctgtgataaa tggaaaggct agattgatca ttatcccaac 6300 gtgtgagcat gtcctcaaag ccgtaataat cagcactaaa ccaacctgtt ttcactttca 6360 ctggtggcgg cagtggctct ccgatctccc ttagcagtgc tgtagctgct cgtccctctt 6420 tgatcacttt atcaagctgc aagcggtcga tattgtcttg caaagccttg taaaatctat 6480 gctctgctcg cttctcatcc gtttttactt caatcaaata cacatctata agcgtttggc 6540 ggtgttgttg gtggtcg tat agtgcctgtt gtgcggtggc atagactgcg ggggcttggt 6600 ctacggcatc ctccagctgc ctcgcgcgtt tcggtgatga cggtgaaaac ctctgacaca 6660 tgcagctccc ggagacggtc acagcttgtc tgtaagcgga tgccgggagc agacaagccc 6720 gtcagggcgc gtcagcgggt gttggcgggt gtcggggcgc agccatgacc cagtcacgta 6780 gcgatagcgg agtgtatact ggcttaacta tgcggcatca gagcagattg tactgagagt 6840 gcaccatatg cggtgtgaaa taccgcacag atgcgtaagg agaaaatacc gcatcaggcg 6900 ctcttccgct tcctcgctca ctgactcgct gcgctcggtc gttcggctgc ggcgagcggt 6960 atcagctcac tcaaaggcgg taatacggtt atccacagaa tcaggggata acgcaggaaa 7020 gaacatgtga gcaaaaggcc agcaaaaggc caggaaccgt aaaaaggccg cgttgctggc 7080 gtttttccat aggctccgcc cccctgacga gcatcacaaa aatcgacgct caagtcagag 7140 gtggcgaaac ccgacaggac tataaagata ccaggcgttt ccccctggaa gctccctcgt 7200 gcgctctcct gttccgaccc tgccgcttac cggatacctg tccgcctttc tcccttcggg 7260 aagcgtggcg ctttctcata gctcacgctg taggtatctc agttcggtgt aggtcgttcg 7320 ctccaagctg ggctgtgtgc acgaaccccc cgttcagccc gaccgctgcg ccttatccgg 7380 taactatcgt cttgagtcca ac ccggtaag acacgactta tcgccactgg cagcagccac 7440 tggtaacagg attagcagag cgaggtatgt aggcggtgct acagagttct tgaagtggtg 7500 gcctaactac ggctacacta gaaggacagt atttggtatc tgcgctctgc tgaagccagt 7560 taccttcgga aaaagagttg gtagctcttg atccggcaaa caaaccaccg ctggtagcgg 7620 tggttttttt gtttgcaagc agcagattac gcgcagaaaa aaaggatctc aagaagatcc 7680 tttgatcttt tctacggggt ctgacgctca gtggaacgaa aactcacgtt aagggatttt 7740 ggtcatgaga ttatcaaaaa ggatcttcac ctagatcctt ttaaattaaa aatgaagttt 7800 taaatcaatc taaagtatat atgagtaaac ttggtctgac agttaccaat gcttaatcag 7860 tgaggcacct atctcagcga tctgtctatt tcgttcatcc atagttgcct gactccccgt 7920 cgtgtagata actacgatac gggagggctt accatctggc cccagtgctg caatgatacc 7980 gcgagaccca cgctcaccgg ctccagattt atcagcaata aaccagccag ccggaagggc 8040 cgagcgcaga agtggtcctg caactttatc cgcctccatc cagtctatta attgttgccg 8100 ggaagctaga gtaagtagtt cgccagttaa tagtttgcgc aacgttgttg ccattgctgc 8160 aggcaagtga agaaatggtg cagcgggcaa cagataatgc aaagcgtaat aatctggtgc 8220 aagcaagctt cttttcacaa gatttaac aa aagatttttc gcatcattct tgggcaaatc 8280 aaggatttga tgcattattg attgatcctc ctcgtgctgg tgcatatgaa attatgcagt 8340 atgtgccgaa ctttggagca aaaagaatcg tttatgtatc atgtaatcca gcaacattag 8400 caagggatgc aggtgttttg gttcaacatg gttaccagtt aaaaaaagca gcggttatgg 8460 acatgtttac gcacacagaa catgttgaat cgattgcttt atttgagaaa attcaagaga 8520 taaacgatta aaaacatgag ttacatatcc aggagaatgg tatgagccat attcaacggg 8580 aaacgtcttg ctcgaggccg cgattaaatt ccaacatgga tgctgattta tatgggtata 8640 aatgggctcg cgataatgtc gggcaatcag gtgcgacaat ctatcgattg tatgggaagc 8700 ccgatgcgcc agagttgttt ctgaaacatg gcaaaggtag cgttgccaat gatgttacag 8760 atgagatggt cagactaaac tggctgacgg aatttatgcc tcttccgacc atcaagcatt 8820 ttatccgtac tcctgatgat gcatggttac tcaccactgc gatccccggg aaaacagcat 8880 tccaggtatt agaagaatat cctgattcag gtgaaaatat tgttgatgcg ctggcagtgt 8940 tcctgcgccg gttgcattcg attcctgttt gtaattgtcc ttttaacagc gatcgcgtat 9000 ttcgtctcgc tcaggcgcaa tcacgaatga ataacggttt ggttgatgcg agtgattttg 9060 atgacgagcg taatggctgg cctgttgaac aag tctggaa agaaatgcat aagcttttgc 9120 cattctcacc ggattcagtc gtcactcatg gtgatttctc acttgataac cttatttttg 9180 acgaggggaa attaataggt tgtattgatg ttggacgagt cggaatcgca gaccgatacc 9240 aggatcttgc catcctatgg aactgcctcg gtgagttttc tccttcatta cagaaacggc 9300 tttttcaaaa atatggtatt gataatcctg atatgaataa attgcagttt catttgatgc 9360 tcgatgagtt tttctaatca gaattggtta attggttgta acactggcag agcattacgc 9420 tgacttgacg ggacggcggc tttgttgaat aaatcgaact tttgctgagt tgaaggatca 9480 gatcacgcat cttcccgaca acgcagaccg ttccgtggca aagcaaaagt tcaaaatcac 9540 caactggtcc acctacaaca aagctctcat caaccgtggc tccctcactt tctggctgga 9600 tgatggggcg attcaggcct ggtatgagtc agcaacacct tcttcacgag gcagacctgc 9660 aggcatcgtg gtgtcacgct cgtcgtttgg tatggcttca ttcagctccg gttcccaacg 9720 atcaaggcga gttacatgat cccccatgtt gtgcaaaaaa gcggttagct ccttcggtcc 9780 tccgatcgtt gtcagaagta agttggccgc agtgttatca ctcatggtta tggcagcact 9840 gcataattct cttactgtca tgccatccgt aagatgcttt tctgtgactg gtgagtactc 9900 aaccaagtca ttctgagaat agtgtatgcg gcgaccgag t tgctcttgcc cggcgtcaac 9960 acgggataat accgcgccac atagcagaac tttaaaagtg ctcatcattg gaaaacgttc 10020 ttcggggcga aaactctcaa ggatcttacc gctgttgaga tccagttcga tgtaacccac 10080 tcgtgcaccc aactgatctt cagcatcttt tactttcacc agcgtttctg ggtgagcaaa 10140 aacaggaagg caaaatgccg caaaaaaggg aataagggcg acacggaaat gttgaatact 10200 catactcttc ctttttcaat attattgaag catttatcag ggttattgtc tcatgagcgg 10260 atacatattt gaatgtattt agaaaaataa acaaataggg gttccgcgca catttccccg 10320 aaaagtgcca cctgacgtct aagaaaccat tattatcatg acattaacct ataaaaatag 10380 gcgtatcacg aggccctttc gtcttcaaga a 10411 <210> 4 <211> 934 <212> DNA <213> Artificial Sequence <220> <223> GlmS upstream <400> 4 tggtttgagc aattgacttg gtgtgccttg ccaagttgag attgcgagtg aattccgtta 60 tcgctcacca gtgattgtgg aaaatacact ttacatctgt atttcacaat caggcgaaac 120 agcggatacc ttagctgcac tacgtgaaac tcaaaaacgt gctaaagcaa ataatatcga 180 tattcagact ttaacgatct gtaacgtcgc aacttcttca atggtgcgtg aaactgatca 240 ccacttattacag accagctttcag tggttg accagcttgcag cacgac 300 tcagcttgct gcattaatgt tgttaatctt gaaaattggt caagtgaaac agcgtattag 360 caatgtgatg attgaagagc ttgctcgtga attgtggcat agcccgaaag tgattcttga 420 tacacttaag aatgatccag aaattttacg tttatcagaa ttgttcgttg aaaaacaaca 480 ctgtttattc ttaggccgtg gcacacacta tccaatcgct ttggaaggtg cattaaagct 540 taaagaaatt tcatatattc acgcagaagg ttatgcagct ggtgagttga aacacggccc 600 attggcactt gttgatactg aaatgccaat cgtgattctt gcaccaaatg acgaaatgct 660 tgataagctt aagtcaaata tggaagaagt tcaggctcgt ggcggtgaat tattcgtttt 720 cgctgatgaa aatagtggtg tagttgaaaa agaccgtcaa catgtcgttc atattccagc 780 agtaaacgaa tggcttgcac caatcattta tagcgtacca gttcagttat tgtcttatca 840 cgttgctgta ttacgtggta cagacgttga ccagccacgt aacttggcga agtcagtaac 900 tgtagagtaa ttcaaaaaag atcattatta aggc 934 <210> 5 <211> 951 <212> DNA <213> Artificial Sequence <220> <223> GlmS downstream <400> 5 atcacctgct ttaataattg attgattaag cccgatatgc attaattgcc tattgggctt 60 ttttattgcc ttcatatcgc tacacagaag ctttcctacg aaagaaaata gagaactctg 120 cttaggtccc cgtgtca caa cggacttttt acttttgcgc tgatttaaag tttgagagat 180 cattgcgaca cagagataaa gaagctaagc gaacttagtc cattttattt ttgtcgcagc 240 gttgaatgct gctgaacaag ttaggggcaa agtcctgtgg gagaacagga ctttgcaaac 300 tggtgtgttt taaacgttgt acggtttgag gtgaatacac ctgtgcaagc tgttggcaaa 360 cacaattaca actggcttac atgtgttcac ctgacaaaca aattctttta aattcctgct 420 gagcattggc atcatcattt gtaatactgt aagcaccgac cacaaggttt aaaatcaata 480 taaatttatg aagtttcata ttattctcat gattatttat aaatttaaat aaaataaaaa 540 tatggttcaa ttaaatatta aaataatttt ttaaataata attaatcctc ccacaaacat 600 aggaaaataa aataattaaa attttaaaat agaaataatt tataaattta aaaaaacagg 660 tcgcaaaaaa cccaaatttt aaataaataa aatagttaac taaaagagaa aatgagtttt 720 aataatggca tggccaactc cttaaaaatg gagttctacc accagattac cgcgaactaa 780 tttagggtgg tagaacgaaa gagggttagc agactgacct agcgaccagc acgcgcgaac 840 gcgtccccct tccgccctac catagagaaa aagggggcac aaaggttcca cacgggtaat 900 actgaggaag tataacccga cacgctaggg tacggtctgc taaaaccgac t 951 <210> 6 <211> 10483 <212> DNA <213> Artificial Sequence <220> <223> pDM4_A1S0579p-npt I <400> 6 gatccttttt gtccggtgtt gggttgaagg tgaagccggt cggggccgca gcgggggccg 60 gcttttcagc cttgcccccc tgcttcggcc gccgtggctc cggcgt cttg ggtgccgt gcc gccgc aggt c gggt gcc gcct 120 cgggt gggt gccg ggcgtg cgagcggaac gtctcgtagg agaacttgac cttccccgtt tcccgcatgt 240 gctcccaaat ggtgacgagc gcatagccgg acgctaacgc cgcctcgaca tccgccctca 300 ccgccaggaa cgcaaccgca gcctcatcac gccggcgctt cttggccgcg cgggattcaa 360 cccactcggc cagctcgtcg gtgtagctct ttggcatcgt ctctcgcctg tcccctcagt 420 tcagtaattt cctgcatttg cctgtttcca gtcggtagat attccacaaa acagcaggga 480 agcagcgctt ttccgctgca taaccctgct tcggggtcat tatagcgatt ttttcggtat 540 atccatcctt tttcgcacga tatacaggat tttgccaaag ggttcgtgta gactttcctt 600 ggtgtatcca acggcgtcag ccgggcagga taggtgaagt aggcccaccc gcgagcgggt 660 gttccttctt cactgtccct tattcgcacc tggcggtgct caacgggaat cctgctctgc 720 gaggctggcc ggctaccgcc ggcgtaacag atgagggcaa gcggatggct gatgaaacca 780 agccaaccag gaagggcagc ccacctatca aggtgtactg ccttccagac gaacgaagag 840 cgattgagga aaaggcggcg gcggccggca tgagcctgtc ggcctacctg ctggccgtcg 900 gccagggcta caaaatcacg ggcgtcgtgg actatgagca cgtccgcgag ctggcccgca 960 tcaatggcga cctgggccgc ctgggcggcc tgctgaaact ctggctcacc gacgacccgc 1020 gcacggcgcg gttcggtgat g ccacgatcc tcgccctgct ggcgaagatc gaagagaagc 1080 aggacgagct tggcaaggtc atgatgggcg tggtccgccc gagggcagag ccatgacttt 1140 tttagccgct aaaacggccg gggggtgcgc gtgattgcca agcacgtccc catgcgctcc 1200 atcaagaaga gcgacttcgc ggagctggtg aagtacatca ccgacgagca aggcaagacc 1260 gagcgcctgg gtcacgtgcg cgtcacgaac tgcgaggcaa acaccctgcc cgctgtcatg 1320 gccgaggtga tggcgaccca gcacggcaac acccgttccg aggccgacaa gacctatcac 1380 ctgctggtta gcttccgcgc gggagagaag cccgacgcgg agacgttgcg cgcgattgag 1440 gaccgcatct gcgctgggct tggcttcgcc gagcatcagc gcgtcagtgc cgtgcatcac 1500 gacaccgaca acctgcacat ccatatcgcc atcaacaaga ttcacccgac ccgaaacacc 1560 atccatgagc cgtatcgggc ctaccgcgcc ctcgctgacc tctgcgcgac gctcgaacgg 1620 gactacgggc ttgagcgtga caatcacgaa acgcggcagc gcgtttccga gaaccgcgcg 1680 aacgacatgg agcggcacgc gggcgtggaa agcctggtcg gctggatccg gccacgatgc 1740 gtccggcgta gaggatctga agatcagcag ttcaacctgt tgatagtacg tactaagctc 1800 tcatgtttca cgtactaagc tctcatgttt aacgtactaa gctctcatgt ttaacgaact 1860 aaaccctcat ggctaacgta ctaagct ctc atggctaacg tactaagctc tcatgtttca 1920 cgtactaagc tctcatgttt gaacaataaa attaatataa atcagcaact taaatagcct 1980 ctaaggtttt aagttttata agaaaaaaaa gaatatataa ggcttttaaa gcttttaagg 2040 tttaacggtt gtggacaaca agccagggat gtaacgcact gagaagccct tagagcctct 2100 caaagcaatt ttgagtgaca caggaacact taacggctga catgggaatt ccacatgtgg 2160 aattccacat gtggaattgt gagcggataa caatttgtgg aatcccggga gagctcaggt 2220 tacccgcatg caagatctat ctagaagggc ccagtcggtt ttagcagacc gtaccctagc 2280 gtgtcgggtt atacttcctc agtattaccc gtgtggaacc tttgtgcccc ctttttctct 2340 atggtagggc ggaaggggga cgcgttcgcg cgtgctggtc gctaggtcag tctgctaacc 2400 ctctttcgtt ctaccaccct aaattagttc gcggtaatct ggtggtagaa ctccattttt 2460 aaggagttgg ccatgccatt attaaaactc attttctctt ttagttaact attttattta 2520 tttaaaattt gggttttttg cgacctgttt ttttaaattt ataaattatt tctattttaa 2580 aattttaatt attttatttt cctatgtttg tgggaggatt aattattatt taaaaaatta 2640 ttttaatatt taattgaacc atatttttat tttatttaaa tttataaata atcatgagaa 2700 taatatgaaa cttcataaat ttatattgat tt taaacctt gtggtcggtg cttacagtat 2760 tacaaatgat gatgccaatg ctcagcagga atttaaaaga atttgtttgt caggtgaaca 2820 catgtaagcc agttgtaatt gtgtttgcca acagcttgca caggtgtatt cacctcaaac 2880 cgtacaacgt ttaaaacaca ccagtttgca aagtcctgtt ctcccacagg actttgcccc 2940 taacttgttc agcagcattc aacgctgcga caaaaataaa atggactaag ttcgcttagc 3000 ttctttatct ctgtgtcgca atgatctctc aaactttaaa tcagcgcaaa agtaaaaagt 3060 ccgttgtgac acggggacct aagcagagtt ctctattttc tttcgtagga aagcttctgt 3120 gtagcgatat gaaggcaata aaaaagccca ataggcaatt aatgcatatc gggcttaatc 3180 aatcaattat taaagcaggt gatgtctgcc tcgtgaagaa ggtgttgctg actcatacca 3240 ggcctgaatc gccccatcat ccagccagaa agtgagggag ccacggttga tgagagcttt 3300 gttgtaggtg gaccagttgg tgattttgaa cttttgcttt gccacggaac ggtctgcgtt 3360 gtcgggaaga tgcgtgatct gatccttcaa ctcagcaaaa gttcgattta ttcaacaaag 3420 ccgccgtccc gtcaagtcag cgtaatgctc tgccagtgtt acaaccaatt aaccaattct 3480 gattagaaaa actcatcgag catcaaatga aactgcaatt tattcatatc aggattatca 3540 ataccatatt tttgaaaaag ccgtttctgt aatgaagg ag aaaactcacc gaggcagttc 3600 cataggatgg caagatcctg gtatcggtct gcgattccga ctcgtccaac atcaatacaa 3660 cctattaatt tcccctcgtc aaaaataagg ttatcaagtg agaaatcacc atgagtgacg 3720 actgaatccg gtgagaatgg caaaagctta tgcatttctt tccagacttg ttcaacaggc 3780 cagccattac gctcgtcatc aaaatcactc gcatcaacca aaccgttatt cattcgtgat 3840 tgcgcctgag cgagacgaaa tacgcgatcg ctgttaaaag gacaattaca aacaggaatc 3900 gaatgcaacc ggcgcaggaa cactgccagc gcatcaacaa tattttcacc tgaatcagga 3960 tattcttcta atacctggaa tgctgttttc ccggggatcg cagtggtgag taaccatgca 4020 tcatcaggag tacggataaa atgcttgatg gtcggaagag gcataaattc cgtcagccag 4080 tttagtctga ccatctcatc tgtaacatca ttggcaacgc tacctttgcc atgtttcaga 4140 aacaactctg gcgcatcggg cttcccatac aatcgataga ttgtcgcacc tgattgcccg 4200 acattatcgc gagcccattt atacccatat aaatcagcat ccatgttgga atttaatcgc 4260 ggcctcgagc aagacgtttc ccgttgaata tggctcatac cattctcctg gatatgtaac 4320 tcatgttttt aatcgtttat ctcttgaatt ttctcaaata aagcaatcga ttcaacatgt 4380 tctgtgtgcg taaacatgtc cataaccgct gcttttttta act ggtaacc atgttgaacc 4440 aaaacacctg catcccttgc taatgttgct ggattacatg atacataaac gattcttttt 4500 gctccaaagt tcggcacata ctgcataatt tcatatgcac cagcacgagg aggatcaatc 4560 aataatgcat caaatccttg atttgcccaa gaatgatgcg aaaaatcttt tgttaaatct 4620 tgtgaaaaga agcttgcttg caccagatta ttacgctttg cattatctgt tgcccgctgc 4680 accatttctt cacttgctgc cttaataatg atcttttttg aattactcta cagttactga 4740 cttcgccaag ttacgtggct ggtcaacgtc tgtaccacgt aatacagcaa cgtgataaga 4800 caataactga actggtacgc tataaatgat tggtgcaagc cattcgttta ctgctggaat 4860 atgaacgaca tgttgacggt ctttttcaac tacaccacta ttttcatcag cgaaaacgaa 4920 taattcaccg ccacgagcct gaacttcttc catatttgac ttaagcttat caagcatttc 4980 gtcatttggt gcaagaatca cgattggcat ttcagtatca acaagtgcca atgggccgtg 5040 tttcaactca ccagctgcat aaccttctgc gtgaatatat gaaatttctt taagctttaa 5100 tgcaccttcc aaagcgattg gatagtgtgt gccacggcct aagaataaac agtgttgttt 5160 ttcaacgaac aattctgata aacgtaaaat ttctggatca ttcttaagtg tatcaagaat 5220 cactttcggg ctatgccaca attcacgagc aagctcttca atcatcaca t tgctaatacg 5280 ctgtttcact tgaccaattt tcaagattaa caacattaat gcagcaagct gagtcgtgaa 5340 cgcttttgtt gatgcaaccc caatctctgg gcctgcaagc gtcaataagt ggtgatcagt 5400 ttcacgcacc attgaagaag ttgcgacgtt acagatcgtt aaagtctgaa tatcgatatt 5460 atttgcttta gcacgttttt gagtttcacg tagtgcagct aaggtatccg ctgtttcgcc 5520 tgattgtgaa atacagatgt aaagtgtatt ttccacaatc actggtgagc gataacggaa 5580 ttcactcgca atctcaactt ggcaaggcac accaagtcaa ttgctcaaac caactagtga 5640 cgcgtactcg agggtcgacg gtatcgataa gcttgatata cactccgcta gcgctgatgt 5700 ccggcggtgc ttttgccgtt acgcaccacc ccgtcagtag ctgaacagga gggacagctg 5760 atagaaacag aagccactgg agcacctcaa aaacaccatc atacactaaa tcagtaagtt 5820 ggcagcatca cccgacgcac tttgcgccga ataaatacct gtgacggaag atcacttcgc 5880 agaataaata aatcctggtg tccctgttga taccgggaag ccctgggcca acttttggcg 5940 aaaatgagac gttgatcggc acgtaagagg ttccaacttt caccataatg aaataagatc 6000 actaccgggc gtattttttg agttatcgag attttcagga gctaargaag ctaaaatgga 6060 gaaaaaaatc actggatata ccaccgttga tatatcccaa tggcatcgta aaga acattt 6120 tgaggcattt cagtcagttg ctcaatgtac ctataaccag accgttcagc tggatattac 6180 ggccttttta aagaccgtaa agaaaaataa gcacaagttt tatccggcct ttattcacat 6240 tcttgcccgc ctgatgaatg ctcatccgga attccgtatg gcaatgaaag acggtgagct 6300 ggtgatatgg gatagtgttc acccttgtta caccgttttc catgagcaaa ctgaaacgtt 6360 ttcatcgctc tggagtgaat accacgacga tttccggcag tttctacaca tatattcgca 6420 agatgtggcg tgttacggtg aaaacctggc ctatttccct aaagggttta ttgagaatat 6480 gtttttcgtc tcagccaatc cctgggtgag tttcaccagt tttgatttaa acgtggccaa 6540 tatggacaac ttcttcgccc ccgttttcac catgggcaaa tattatacgc aaggcgacaa 6600 ggtgctgatg ccgctggcga ttcaggttca tcatgccgtt tgtgatggct tccatgtcgg 6660 cagaatgctt aatgaattac aacagtactg cgatgagtgg cagggcgggg cgtaattttt 6720 ttaaggcagt tattggtgcc cttaaacgcc tggttgctac gcctgaataa gtgataataa 6780 gcggatgaat ggcagaaatt cgaaagcaaa ttcgacccgg tcgtcggttc agggcagggt 6840 cgttaaatag ccgcttatgt ctattgctgg tttaccggtt tattgactac cggaagcagt 6900 gtgaccgtgt gcttctcaaa tgcctgaggc cagwttgctc agctctcccg tggaggtaat 6960 aattgacgat atgatcattt attctgcctc ccagagcctg ataaaaacgg ttagcgcttc 7020 gttaatacag atgtaggtgt tccacagggt agccagcagc atcctgcgat gcagatcatc 7080 gaattcctgc agccaagcta gacctaggcc ttaagatcct ttttaaccca tcacatatac 7140 ctgccgttca ctattattta gtgaaatgag atattatgat attttctgaa ttgtgattaa 7200 aaaggcaact ttatgcccat gcaacagaaa ctataaaaaa tacagagaat gaaaagaaac 7260 agatagattt tttagttctt taggcccgta gtctgcaaat ccttttatga ttttctatca 7320 aacaaaagag gaaaatagac cagttgcaat ccaaacgaga gtctaataga atgaggtcga 7380 aaagtaaatc gcgcgggttt gttactgata aagcaggcaa gacctaaaat gtgtaaaggg 7440 caaagtgtat actttggcgt caccccttac atattttagg tcttttttta ttgtgcgtaa 7500 ctaacttgcc atcttcaaac aggagggctg gaagaagcag accgctaaca cagtacataa 7560 aaaaggagac atgaacgatg aacatcaaaa agtttgcaaa acaagcaaca gtattaacct 7620 ttactaccgc actgctggca ggaggcgcaa ctcaagcgtt tgcgaaagaa acgaaccaaa 7680 agccatataa ggaaacatac ggcatttccc atattacacg ccatgatatg ctgcaaatcc 7740 ctgaacagca aaaaaatgaa aaatatcaag ttcctgaatt cgattcgtcc acaattaaaa 7800 atatctcttc tgcaaaaggc ctggacgttt gggacagctg gccattacaa aacgctgacg 7860 gcactgtcgc aaactatcac ggctaccaca tcgtctttgc attagccgga gatcctaaaa 7920 atgcggatga cacatcgatt tacatgttct atcaaaaagt cggcgaaact tctattgaca 7980 gctggaaaaa cgctggccgc gtctttaaag acagcgacaa attcgatgca aatgattcta 8040 tcctaaaaga ccaaacacaa gaatggtcag gttcagccac atttacatct gacggaaaaa 8100 tccgtttatt ctacactgat ttctccggta aacattacgg caaacaaaca ctgacaactg 8160 cacaagttaa cgtatcagca tcagacagct ctttgaacat caacggtgta gaggattata 8220 aatcaatctt tgacggtgac ggaaaaacgt atcaaaatgt acagcagttc atcgatgaag 8280 gcaactacag ctcaggcgac aaccatacgc tgagagatcc tcactacgta gaagataaag 8340 gccacaaata cttagtattt gaagcaaaca ctggaactga agatggctac caaggcgaag 8400 aatctttatt taacaaagca tactatggca aaagcacatc attcttccgt caagaaagtc 8460 aaaaacttct gcaaagcgat aaaaaacgca cggctgagtt agcaaacggc gctctcggta 8520 tgattgagct aaacgatgat tacacactga aaaaagtgat gaaaccgctg attgcatcta 8580 acacagtaac agatgaaatt gaacgcgcga acgtctttaa aatgaacggc aaatggtacc 8640 tgttca ctga ctcccgcgga tcaaaaatga cgattgacgg cattacgtct aacgatattt 8700 acatgcttgg ttatgtttct aattctttaa ctggcccata caagccgctg aacaaaactg 8760 gccttgtgtt aaaaatggat cttgatccta acgatgtaac ctttacttac tcacacttcg 8820 ctgtacctca agcgaaagga aacaatgtcg tgattacaag ctatatgaca aacagaggat 8880 tctacgcaga caaacaatca acgtttgcgc caagcttcct gctgaacatc aaaggcaaga 8940 aaacatctgt tgtcaaagac agcatccttg aacaaggaca attaacagtt aacaaataaa 9000 aacgcaaaag aaaatgccga tatcctatng gcattttctt ttatttctta tcaacataaa 9060 ggtgaatccc atatgaacta tataaaagca ggcaaatggc taaccgtatt cctaaccttt 9120 tggtaatgac tccaacttat tgatagtgtt ttatgttcag ataatgcccg atgactttgt 9180 catgcagctc caccgatttt gagaacgaca gcgacttccg tcccagccgt gccaggtgct 9240 gcctcagatt caggttatgc cgctcaattc gctgcgtata tcgcttgctg attacgtgca 9300 gctttccctt caggcgggat tcatacagcg gccagccatc cgtcatccat atcaccacgt 9360 caaagggtga cagcaggctc ataagacgcc ccagcgtcgc catagtgcgt tcaccgaata 9420 cgtgcgcaac aaccgtcttc cggagactgt catacgcgta aaacagccag cgctggcgcg 9480 atttagcccc g acatagccc cactgttcgt ccatttccgc gcagacgatg acgtcactgc 9540 ccggctgtat gcgcgaggtt accgactgcg gcctgagttt tttaagtgac gtaaaatcgt 9600 gttgaggcca acgcccataa tgcgggctgt tgcccggcat ccaacgccat tcatggccat 9660 atcaatgatt ttctggtgcg taccgggttg agaagcggtg taagtgaact gcagcaatgg 9720 caacaacgtt gcgcaaacta ttaactggcg aactacttac tctagcttcc cggcaacaat 9780 taatagactg gatggaggcg gataaagttg caggaccact tctgcgctcg gcccttccgg 9840 ctggctggtt tattgctgat aaatctggag ccggtgagcg tgggtctcgc ggtatcattg 9900 cagcactggg gccagatggt aagccctccc gtatcgtagt tatctacacg acggggagtc 9960 aggcaactat ggatgaacga aatagacaga tcgctgagat aggtgcctca ctgattaagc 10020 attggtaact gtcagaccaa gtttactcat atatacttta gattgattta tggtgcactc 10080 tcagtacaat ctgctctgat gccgcatagt taagccagta tacactccgc tatcgctacg 10140 tgactgggtc atggctgcgc cccgacaccc gccaacaccc gctgacgcgc cctgacgggc 10200 ttgtctgctc ccggcatccg cttacagaca agctgtgacc gtctccggga gctgcatgtg 10260 tcagaggttt tcaccgtcat caccgaaacg cgcgaggcag caaggagatg gcgcccaaca 10320 gtcccccggc c acggggcct gccaccatac ccacgccgaa acaagcgctc atgagcccga 10380 agtggcgagc ccgatcttcc ccatcggtga tgtcggcgat ataggcgcca gcaaccgcac 10440 ctgtggcgcc ggtgatgccg gccacgatgc gtccggcgta gag 10483 <210> 7 <211> 29 <212> DNA <213> Artificial Sequence <220> <223> Primer - GlmS_Up_F_spe I <400> 7 ggactagttg gtttgagcaa ttgacttgg 29 <210> 8 <211> 45 <212> DNA <213> Artificial Sequence <220> <223> Primer - GlmS_Up_R <400> 8 cttcacttgc tgccttaata atgatctttt ttgaattact ctaca 45 <210> 9 <211> 50212 > DNA <213> Artificial Sequence <220> <223> Primer - A1S_0579p_F <400> 9 gtaattcaaa aaagatcatt attaaggcag caagtgaaga aatggtgcag 50 <210> 10 <211> 32 <212> DNA <213> Artificial Sequence <220> <223> Primer - A1S_0579p_R <400> 10 tggctcatac cattctcctg gatatgtaac tc 32 <210> 11 <211> 34 <212> DNA <213> Artificial Sequence <220> <223> Primer - Npt I_F <400> 11 caggagaatg gtatgagcca tattcaacgg gaaa 34 <210> 12 <211> 28 <212> DNA <213> Artificial Sequence <220> <223> Primer - Npt I_R <400> 12 gcaggtgatg tctgcctcgt ga agaagg 28 <210> 13 <211> 39 <212> DNA <213> Artificial Sequence <220> <223> Primer - GlmS_Down_F <400> 13 aggcagacat cacctgcttt aataattgat tgattaagc 39 <210> 14 <211> 28 <212> DNA < 213> Artificial Sequence <220> <223> Primer - GlmS_Down_R_Apa I <400> 14 gttgggccca gtcggtttta gcagaccg 28 <210> 15 <211> 29 <212> DNA <213> Artificial Sequence <220> <223> Primer - A1S_0579p_F_pst I < 400> 15 aactgcaggc aagtgaagaa atggtgcag 29 <210> 16 <211> 27 <212> DNA <213> Artificial Sequence <220> <223> Primer - Npt I_R_pst I<400> 16 aactgcaggt ctgcctcgtg aagaagg 27
Claims (11)
상기 프로모터는 아시네토박터 바우마니(Acinetobacter baumannii)의 ppGpp 생합성 관련 유전자의 프로모터 부위인 것이고,
상기 ppGpp 생합성 관련 유전자는 서열번호 1의 염기서열을 포함하는 A1S_0579인 것이고,
상기 재조합 플라스미드는 서열번호 3으로 표시되는 염기서열을 갖는 것인, 재조합 플라스미드.
a promoter consisting of the nucleotide sequence represented by SEQ ID NO: 1; And as a recombinant plasmid for screening ppGpp biosynthesis-related gene expression inhibitors in which antibiotic resistance genes are sequentially operably linked,
The promoter is the promoter region of the ppGpp biosynthesis-related gene of Acinetobacter baumannii ,
The ppGpp biosynthesis-related gene is A1S_0579 comprising the nucleotide sequence of SEQ ID NO: 1,
The recombinant plasmid will have the nucleotide sequence represented by SEQ ID NO: 3, the recombinant plasmid.
상기 프로모터는 아시네토박터 바우마니(Acinetobacter baumannii)의 ppGpp 생합성 관련 유전자의 프로모터 부위인 것이고,
상기 ppGpp 생합성 관련 유전자는 서열번호 1의 염기서열을 포함하는 A1S_0579인 것이고,
상기 재조합 플라스미드는 서열번호 6으로 표시되는 염기서열을 갖는 것인, 재조합 플라스미드.
a nucleic acid region homologous to the 5' end of the target gene; a promoter consisting of the nucleotide sequence represented by SEQ ID NO: 1; antibiotic resistance gene; And as a recombinant plasmid for screening ppGpp biosynthesis-related gene expression inhibitors in which a nucleic acid region homologous to the 3' end of the target gene is sequentially operably linked,
The promoter is the promoter region of the ppGpp biosynthesis-related gene of Acinetobacter baumannii ,
The ppGpp biosynthesis-related gene is A1S_0579 comprising the nucleotide sequence of SEQ ID NO: 1,
The recombinant plasmid will have the nucleotide sequence shown in SEQ ID NO: 6, the recombinant plasmid.
상기 항생제 저항성 유전자는 nptI 유전자인 것인, 재조합 플라스미드.
The method according to claim 1 or 2,
The antibiotic resistance gene is the nptI gene, the recombinant plasmid.
상기 표적 유전자는 glmS 유전자인 것인, 재조합 플라스미드.
3. The method according to claim 2,
The target gene is a glmS gene, the recombinant plasmid.
A method for producing a mutant strain for screening for ppGpp biosynthesis-related gene expression inhibitors, comprising the step of introducing the recombinant plasmid of claim 1 or 2 into a microorganism to obtain a transformant.
A mutant strain for screening for ppGpp biosynthesis-related gene expression inhibitors prepared by the method of claim 8.
b) 상기 돌연변이 균주에 시험물질을 접촉시키는 단계
를 포함하는 ppGpp 생합성 관련 유전자 발현 저해물질의 탐색 방법.
a) culturing the mutant strain of claim 9 in a solid medium containing antibiotics; and
b) contacting the mutant strain with a test substance
A screening method for ppGpp biosynthesis-related gene expression inhibitors comprising a.
상기 a) 단계의 항생제는 카나마이신인 것인, 방법.
11. The method of claim 10,
Wherein the antibiotic of step a) is kanamycin, the method.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200084688A KR102454110B1 (en) | 2020-07-09 | 2020-07-09 | Recombinant plasmids and mutant strains for screening inhibitors of ppGpp biosynthesis-related gene expression |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200084688A KR102454110B1 (en) | 2020-07-09 | 2020-07-09 | Recombinant plasmids and mutant strains for screening inhibitors of ppGpp biosynthesis-related gene expression |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20220006810A KR20220006810A (en) | 2022-01-18 |
KR102454110B1 true KR102454110B1 (en) | 2022-10-14 |
Family
ID=80052383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200084688A KR102454110B1 (en) | 2020-07-09 | 2020-07-09 | Recombinant plasmids and mutant strains for screening inhibitors of ppGpp biosynthesis-related gene expression |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102454110B1 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101731837B1 (en) * | 2015-02-06 | 2017-05-04 | 충남대학교산학협력단 | Recombinant plasmid for screening inhibitors of ompA expression |
-
2020
- 2020-07-09 KR KR1020200084688A patent/KR102454110B1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
KR20220006810A (en) | 2022-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Alting-Mees et al. | [42] pBluescriptII: Multifunctional cloning and mapping vectors | |
US6372457B1 (en) | Process and materials for production of glucosamine | |
CN109777761B (en) | Construction and application of engineering bacteria for secretory expression of chitobiose deacetylase | |
KR20120051705A (en) | Transformant and process for production thereof, and process for production of lactic acid | |
CN102002509B (en) | Escherichia coli-bacillus subtilis shuttle expression vector and application thereof | |
CN112225822B (en) | CAR-iNKT with high amplification, survival ability and tumor killing effect and application thereof | |
CN107604004A (en) | Tracer target practice plasmid for vaccinia virus Tiantan strain TK genes and preparation method thereof | |
CN108718529B (en) | Mutant microorganism for producing L-cysteine and method for producing L-cysteine using the same | |
CN110944656B (en) | Novel polynucleotides encoding human FKRP proteins | |
WO1992017581A1 (en) | Mammalian expression vector | |
CN101463362B (en) | Expression vector for fusion expression of green fluorescent protein, construction method and use thereof | |
US5700665A (en) | Method for the extraction of periplasmic proteins from prokaryotic microorganisms in the presence of arginine | |
CN114032217A (en) | Novel coronavirus compound vaccine based on DNA vector and replicative vaccinia virus vector | |
KR102454110B1 (en) | Recombinant plasmids and mutant strains for screening inhibitors of ppGpp biosynthesis-related gene expression | |
CN113046369B (en) | Novel mRNA vaccine of coronavirus | |
CN100429309C (en) | 100bp gradient ribonucleic acid molecular weight marker and its preparation | |
CN114164225B (en) | High-throughput screening tool for enabling escherichia coli to obtain effective NHEJ system and application of high-throughput screening tool | |
CN110607267B (en) | Sheep listeria balanced lethal system, construction method and application | |
CN114277047B (en) | Application of high-throughput screening tool for obtaining effective NHEJ system from escherichia coli in escherichia coli gene editing | |
CN111206024B (en) | Engineering bacterium for expressing pectate endo-hydrolase and application thereof | |
CN111560392B (en) | MiRNA expression vector and application thereof | |
KR20120043657A (en) | Method for mass production of factor vii/viia | |
CN101220374A (en) | Fowl pox virus double-gene expression carrier (PG7.5N) | |
CN114716520B (en) | Pichia kudriavzevii tricarboxylic acid transporter as well as encoding gene and application thereof | |
CN108385170B (en) | Regulatory sequence library of Bacillus subtilis F4 promoter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |